Acreage (ACRDF) 10-Q 10 May 22 2022 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Mar. 31, 2022	May 03, 2022
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2022
Document Transition Report	false
Entity File Number	000-56021
Entity Registrant Name	ACREAGE HOLDINGS, INC.
Entity Incorporation, State or Country Code	A1
Entity Tax Identification Number	98-1463868
Entity Address, Address Line One	450 Lexington Ave, #3308
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10163
City Area Code	646
Local Phone Number	600-9181
Title of 12(g) Security	Class D Subordinate Voting Shares, no par value; Class E Subordinate Voting Shares, no par value.
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2022
Entity Central Index Key	0001762359
Class E Subordinate Voting Shares
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		75,511,350
Class D Subordinate Voting Shares
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		33,467,215
Class F Multiple Voting Shares
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		117,600

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
ASSETS
Cash and cash equivalents	$ 32,619	$ 43,180
Restricted cash	95	1,098
Accounts receivable, net	6,795	8,202
Inventory	48,698	41,804
Notes receivable, current	2,222	7,104
Short-term investments	3,401	0
Assets held-for-sale	6,311	8,952
Other current assets	3,513	2,639
Total current assets	103,654	112,979
Long-term investments	36,014	35,226
Notes receivable, non-current	27,633	27,563
Capital assets, net	142,068	126,797
Operating lease right-of-use assets	24,571	24,598
Intangible assets, net	118,699	119,695
Goodwill	43,534	43,310
Other non-current assets	1,640	1,383
Total non-current assets	394,159	378,572
TOTAL ASSETS	497,813	491,551
LIABILITIES AND SHAREHOLDERS’ EQUITY
Accounts payable and accrued liabilities	26,255	23,861
Taxes payable	30,643	24,572
Interest payable	2,562	1,432
Operating lease liability, current	2,343	2,145
Debt, current	7,370	1,583
Non-refundable deposits on sale	1,000	1,000
Liabilities related to assets held for sale	1,669	1,867
Other current liabilities	11,298	10,333
Total current liabilities	83,140	66,793
Debt, non-current	169,282	169,151
Operating lease liability, non-current	24,146	24,255
Deferred tax liability	26,727	27,082
Total non-current liabilities	220,155	220,488
TOTAL LIABILITIES	303,295	287,281
Commitments and contingencies
Common stock, no par value - unlimited authorized, 107,411 and 106,903 issued and outstanding, respectively	0	0
Additional paid-in capital	760,700	756,536
Treasury stock, 842 common stock held in treasury	(21,054)	(21,054)
Accumulated deficit	(550,909)	(538,215)
Total Acreage Shareholders' equity	188,737	197,267
Non-controlling interests	5,781	7,003
TOTAL EQUITY	194,518	204,270
TOTAL LIABILITIES AND EQUITY	$ 497,813	$ 491,551

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Parenthetical) - shares shares in Thousands	Mar. 31, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Common stock, issued (shares)	107,411	106,903
Common stock, shares, outstanding (in shares)	107,411	106,903
Treasury stock (in shares)	842	842

UNAUDITED CONDENSED CONSOLIDATE

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
REVENUE
Total revenues, net	$ 56,879	$ 38,393
Total cost of goods sold	(27,369)	(17,772)
Gross profit	29,510	20,621
OPERATING EXPENSES
General and administrative	8,387	9,218
Compensation expense	14,195	10,362
Equity-based compensation expense	4,159	6,042
Marketing	697	12
Impairments, net	2,138	818
Write down (recovery) of assets held-for-sale	874	(8,616)
Loss on legal settlements	(25)	10
Depreciation and amortization	1,807	969
Total operating expenses	32,232	18,815
Net operating income (loss)	(2,722)	1,806
Income (loss) from investments, net	1,133	(144)
Interest income from loans receivable	417	1,465
Interest expense	(4,781)	(4,857)
Other loss, net	(10)	(1,566)
Total other loss	(3,241)	(5,102)
Loss before income taxes	(5,963)	(3,296)
Income tax expense	(7,948)	(5,346)
Net loss	(13,911)	(8,642)
Less: net loss attributable to non-controlling interests	(1,217)	(833)
Net loss attributable to Acreage Holdings, Inc.	$ (12,694)	$ (7,809)
Net loss per share attributable to Acreage Holdings, Inc. Basic (USD per share)	$ (0.12)	$ (0.08)	[1]
Net loss per share attributable to Acreage Holdings, Inc, Diluted (USD per share)	$ (0.12)	$ (0.08)	[1]
Weighted average shares outstanding basic (in share)	106,900	102,343	[1]
Weighted average shares outstanding diluted (in share)	106,900	102,343	[1]
Retail
REVENUE
Total revenues, net	$ 41,427	$ 25,847
Total cost of goods sold	(20,768)	(13,082)
Wholesale
REVENUE
Total revenues, net	15,172	10,016
Total cost of goods sold	(6,601)	(4,690)
Other
REVENUE
Total revenues, net	$ 280	$ 2,530
[1]	Presentation of March 31, 2021 figures have been revised.

UNAUDITED CONDENSED CONSOLIDA_2

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Share Capital	Treasury Stock	Accumulated Deficit	Shareholders’ Equity	Non-controlling Interests	LLC Membership Units	Pubco Shares (as converted)
Beginning balance (in shares) at Dec. 31, 2020							3,861	101,250
Beginning balance at Dec. 31, 2020	$ 259,709	$ 737,290	$ (21,054)	$ (475,205)	$ 241,031	$ 18,678
Increase (Decrease) in Stockholders' Equity
Purchase of non-controlling interest in subsidiary	(286)	(272)			(272)	(14)
NCI adjustments for changes in ownership (shares)								400
NCI adjustments for changes in ownership	0	601			601	(601)
Capital distributions, net	(30)					(30)
Other equity transactions (shares)								97
Other equity transactions	300	300			300
Equity-based compensation expense and related issuances (shares)								1,693
Equity-based compensation expense and related issuances	6,042	6,042			6,042
Net loss	(8,642)			(7,809)	(7,809)	(833)
Ending balance (in shares) at Mar. 31, 2021							3,861	103,440
Ending balance at Mar. 31, 2021	257,093	743,961	(21,054)	(483,014)	239,893	17,200
Beginning balance (in shares) at Dec. 31, 2021							3,861	106,903
Beginning balance at Dec. 31, 2021	204,270	756,536	(21,054)	(538,215)	197,267	7,003
Increase (Decrease) in Stockholders' Equity
NCI adjustments for changes in ownership	0	5			5	(5)
Equity-based compensation expense and related issuances (shares)								508
Equity-based compensation expense and related issuances	4,159	4,159			4,159
Net loss	(13,911)			(12,694)	(12,694)	(1,217)
Ending balance (in shares) at Mar. 31, 2022							3,861	107,411
Ending balance at Mar. 31, 2022	$ 194,518	$ 760,700	$ (21,054)	$ (550,909)	$ 188,737	$ 5,781

UNAUDITED CONDENSED CONSOLIDA_3

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (13,911)	$ (8,642)
Adjustments for:
Depreciation and amortization	1,807	969
Depreciation and amortization included in COGS	1,084	552
Equity-based compensation expense	4,159	6,042
Loss on disposal of capital assets	49	1,592
Loss on impairment	2,138	818
Bad debt expense	(96)	0
Non-cash interest expense	644	1,119
Non-cash operating lease expense	(9)	(391)
Deferred tax (income) expense	(279)	(400)
Non-cash income from investments, net	(788)	(157)
Other non-cash (income) expense, net	0	(2,500)
(Recovery) write-down of assets held-for-sale	874	(8,616)
Change, net of acquisitions in:
Inventory	(7,002)	(1,736)
Other assets	(62)	(1,289)
Interest receivable	(417)	292
Accounts payable and accrued liabilities	(1,856)	(1,328)
Taxes payable	6,071	4,618
Interest payable	1,130	2,184
Other liabilities	1,101	5,284
Net cash used in operating activities	(5,363)	(1,589)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of capital assets	(8,290)	(5,421)
Investments in notes receivable	0	(1,229)
Collection of notes receivable	5,279	86
Cash paid for long-term investments	0	302
Proceeds from sale of capital assets	0	5
Business acquisitions, net of cash acquired	0	(286)
Distributions from investments	345	13
Cash paid for short-term investment	(3,400)	0
Net cash used in investing activities	(6,066)	(6,530)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from financing	0	1,190
Deferred financing costs paid	(11)	0
Proceeds from issuance of private placement units and warrants, net	0	301
Repayment of debt	0	(2,070)
Net cash used in financing activities	(11)	(579)
Net decrease in cash, cash equivalents, restricted cash, and cash held for sale	(11,440)	(8,698)
Cash, cash equivalents, restricted cash, and cash held for sale - Beginning of period	44,501	54,639
Cash, cash equivalents, restricted cash, and cash held for sale - End of period	33,061	45,941
RECONCILIATION OF CASH FLOW INFORMATION:
Cash and cash equivalents	32,619	22,844
Restricted cash	95	23,097
Cash held for sale	347	0
Total cash, cash equivalents, restricted cash, and cash held for sale at end of period	33,061	45,941
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest paid - non-lease	2,446	1,555
Income taxes paid	2,065	1,044
OTHER NON-CASH INVESTING AND FINANCING ACTIVITIES:
Capital assets not yet paid for	3,631	1,805
Non-cash proceeds from finance lease	$ 5,785	$ 0

NATURE OF OPERATIONS

NATURE OF OPERATIONS	3 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
NATURE OF OPERATIONS	NATURE OF OPERATIONS Acreage Holdings, Inc. (the “Company”, “Pubco” or “Acreage”) is a vertically integrated, multi-state operator in the United States (“U.S.”) cannabis industry and has contractual relationships with cannabis cultivation facilities, dispensaries and other cannabis-related companies in the U.S. The Company’s operations include (i) cultivating and processing cannabis plants, (ii) manufacturing branded consumer products, (iii) distributing cannabis flower and manufactured products, and (iv) retailing dosable cannabis products to consumers. The Company’s products appeal to medical and adult recreational use customers through brand strategies intended to build trust and loyalty. The Company’s Class E subordinate voting shares (“Fixed Shares”) and Class D subordinate voting shares (“Floating Shares”) are listed on the Canadian Securities Exchange under the symbols “ACRG.A.U” and “ACRG.B.U”, respectively, quoted on the OTCQX under the symbols “ACRHF” and “ACRDF”, respectively, and traded on the Frankfurt Stock Exchange under the symbols “0VZ1” and “0VZ2”, respectively. High Street Capital Partners, LLC, a Delaware limited liability company doing business as “Acreage Holdings” (“HSCP”), was formed on April 29, 2014. The Company became the indirect parent of HSCP on November 14, 2018 in connection with the reverse takeover (“RTO”) transaction described below. The Company’s principal place of business is located at 450 Lexington Avenue, #3308, New York, New York in the U.S. The Company’s registered and records office address is Suite 2800, Park Place, 666 Burrard Street, Vancouver, British Columbia in Canada. The RTO transaction On September 21, 2018, the Company, HSCP, HSCP Merger Corp. (a wholly-owned subsidiary of the Company), Acreage Finco B.C. Ltd. (a special purpose corporation) (“Finco”), Acreage Holdings America, Inc. (“USCo”) and Acreage Holdings WC, Inc. (“USCo2”) entered into a business combination agreement (the “Business Combination Agreement”) whereby the parties thereto agreed to combine their respective businesses, which would result in the RTO of Pubco by the security holders of HSCP, which was deemed to be the accounting acquiror. On November 14, 2018, the parties to the Business Combination Agreement completed the RTO. Canopy Growth Corporation transaction On June 27, 2019, the Company and Canopy Growth Corporation (“Canopy Growth” or “CGC”) implemented the Prior Plan of Arrangement (as defined in Note 13) contemplated by the Original Arrangement Agreement (as defined in Note 13). Pursuant to the Prior Plan of Arrangement, Canopy Growth was granted an option to acquire all of the issued and outstanding shares of the Company in exchange for the payment of 0.5818 of a common share in the capital of Canopy Growth for each Class A subordinate voting share (each, a “SVS”) held (with the Class B proportionate voting shares (the “PVS”) and Class C multiple voting shares (the “MVS”) being automatically converted to SVS immediately prior to consummation of the Acquisition (as defined in Note 13), which original exchange ratio was subject to adjustment in accordance with the Original Arrangement Agreement. Canopy Growth was required to exercise the option upon a change in federal laws in the United States to permit the general cultivation, distribution and possession of marijuana (as defined in the relevant legislation) or to remove the regulation of such activities from the federal laws of the United States (the “Triggering Event”) and, subject to the satisfaction or waiver of certain closing conditions set out in the Original Arrangement Agreement, Canopy Growth was required to acquire all of the issued and outstanding SVS (following the mandatory conversion of the PVS and MVS into SVS). On June 24, 2020, Canopy Growth and the Company entered into an agreement to, among other things, amend the terms of the Original Arrangement Agreement and the terms of the Prior Plan of Arrangement (the “Amended Arrangement”). On September 16, 2020, the Company’s shareholders voted in favor of a special resolution authorizing and approving the terms of, among other things, the Amended Arrangement. Subsequently, on September 18, 2020, the Company obtained a final order from the Supreme Court of British Columbia approving the Amended Arrangement, and on September 23, 2020 the Company and Canopy Growth entered into the Amending Agreement (as defined in Note 13) and implemented the Amended Arrangement. Pursuant to the Amended Arrangement, the Company’s articles were amended to create the Fixed Shares, the Floating Shares and the Class F multiple voting shares (the “Fixed Multiple Shares”), and each outstanding SVS was exchanged for 0.7 of a Fixed Share and 0.3 of a Floating Share, each outstanding PVS was exchanged for 28 Fixed Shares and 12 Floating Shares; and each outstanding MVS was exchanged for 0.7 of a Fixed Multiple Share and 0.3 of a Floating Share. Refer to Note 13 for further discussion. Pursuant to the implementation of the Amended Agreement, on September 23, 2020, a subsidiary of Canopy Growth advanced gross proceeds of $50,000 to Universal Hemp, LLC, an affiliate of the Company. The debenture bears interest at a rate of 6.1% per annum. Refer to Note 10 for further discussion. COVID-19 In December 2019, a novel strain of coronavirus (“COVID-19”) emerged in Wuhan, China. Since then, it has spread to other countries and infections have been reported around the world. On March 11, 2020, the World Health Organization declared the outbreak of COVID-19 a global pandemic. In response to the outbreak, governmental authorities in the United States, Canada and internationally have introduced various recommendations and measures to try to limit the pandemic, including travel restrictions, border closures, non-essential business closures, quarantines, self-isolations, shelters-in-place and social distancing. The COVID-19 outbreak and the response of governmental authorities to try to limit it are having a significant impact on the private sector and individuals, including unprecedented business, employment and economic disruptions. Management has been closely monitoring the impact of COVID-19, with a focus on the health and safety of the Company’s employees, business continuity and supporting the communities where the Company operates. The company has implemented various measures to reduce the spread of the virus, including implementing social distancing measures at its cultivation facilities, manufacturing facilities, and dispensaries, enhancing cleaning protocols at such facilities and dispensaries and encouraging employees to adhere to preventative measures recommended by local, state, and federal health officials. Despite some impact to our day-to-day operations at select locations from time-to-time, COVID-19 has had a minimal impact overall on the Company’s performance.

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
SIGNIFICANT ACCOUNTING POLICIES	SIGNIFICANT ACCOUNTING POLICIES Basis of presentation and going concern The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, all adjustments consisting only of normal recurring adjustments necessary for a fair presentation have been reflected in these unaudited condensed consolidated financial statements. Operating results for the interim periods presented are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2022, or any other period. As reflected in the unaudited condensed consolidated financial statements, the Company had an accumulated deficit as of March 31, 2022, as well as a net loss and negative cash flow from operating activities for the three months ended March 31, 2022. These factors raise substantial doubt about the Company’s ability to continue as a going concern for at least one year from the issuance of these financial statements. However, management believes that substantial doubt about the Company’s ability to meet its obligations for the next twelve months from the date these financial statements were issued has been alleviated due to, but not limited to, (i) access to future capital commitments, (ii) continued sales growth from the Company’s consolidated operations, (iii) latitude as to the timing and amount of certain operating expenses as well as capital expenditures, (iv) restructuring plans that have already been put in place to improve the Company’s profitability, (v) the AFC-VRT credit facilities (refer to Note 10 for further discussion), and (vi) the anticipated Non-Core Divestitures (refer to Note 3 for further discussion), as well as access to the U.S. public equity markets. If the Company is unable to raise additional capital whenever necessary, it may be forced to decelerate or curtail its footprint build-out or other operational activities until such time as additional capital becomes available. Such limitation of the Company’s activities would allow it to slow its rate of spending and extend its use of cash until additional capital is raised. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. Management also cannot provide any assurance as to unforeseen circumstances that could occur at any time within the next twelve months or thereafter which could increase the Company’s need to raise additional capital on an immediate basis. These interim unaudited condensed consolidated financial statements and notes thereto should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, dated March 11, 2022, as filed with the Securities and Exchange Commission (the “2021 Form 10-K”). Use of estimates The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Preparation of financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities as of the dates presented and the reported amounts of revenues and expenses during the periods presented. Actual results could differ from those estimates. Significant estimates inherent in the preparation of the accompanying unaudited condensed consolidated financial statements include the fair value of assets acquired and liabilities assumed in business combinations, assumptions relating to equity-based compensation expense, estimated useful lives for property, plant and equipment and intangible assets, the valuation allowance against deferred tax assets and the assessment of potential charges on goodwill, intangible assets and investments in equity and notes receivable. Emerging growth company The Company is an “emerging growth company” as defined in the Jumpstart Our Business Startups Act (the “JOBS Act”). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards until such time as those standards apply to private companies. Functional and presentation currency The unaudited condensed consolidated financial statements and the accompanying notes are expressed in U.S. dollars. Financial metrics are presented in thousands. Other metrics, such as shares outstanding, are presented in thousands unless otherwise noted. Basis of consolidation The Company’s unaudited condensed consolidated financial statements include the accounts of Acreage, its subsidiaries and variable interest entities (“VIEs”) where the Company is considered the primary beneficiary, if any, after elimination of intercompany accounts and transactions. Investments in business entities in which Acreage lacks control but is able to exercise significant influence over operating and financial policies are accounted for using the equity method. The Company’s proportionate share of net income or loss of the entity is recorded in Income (loss) from investments, net in the Unaudited Condensed Consolidated Statements of Operations. VIEs In determining whether the Company is the primary beneficiary of a VIE, the Company assesses whether it has the power to direct matters that most significantly impact the activities of the VIE and have the obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE. There were no material consolidated VIEs as of March 31, 2022 or December 31, 2021. Non-controlling interests (“NCI”) Non-controlling interests represent ownership interests in consolidated subsidiaries by parties that are not shareholders of Pubco. They are shown as a component of Total equity in the Unaudited Condensed Consolidated Statements of Financial Position, and the share of loss attributable to non-controlling interests is shown as a component of Net loss in the Unaudited Condensed Consolidated Statements of Operations. Changes in the parent company’s ownership that do not result in a loss of control are accounted for as equity transactions. Restricted cash Restricted cash represents funds contractually held for specific purposes and, as such, not available for general corporate purposes. Cash and restricted cash, as presented on the Unaudited Condensed Consolidated Statements of Cash Flows, consists of $32,619 and $95 as of March 31, 2022, respectively, and $22,844 and $23,097 as of March 31, 2021, respectively. Accounts receivable valuations and reclassifications Accounts receivable are stated at their net realizable value. The allowance against gross trade receivables reflects the best estimate of probable losses inherent in the receivables portfolio determined on the basis of historical experience, specific allowances for known troubled accounts and other currently available information. As of March 31, 2022 and December 31, 2021, the Company’s allowance for doubtful accounts was $350 and $445, respectively. Net loss per share Net loss per share represents the net loss attributable to shareholders divided by the weighted average number of shares outstanding during the period on an as converted basis. Basic and diluted loss per share are the same as of March 31, 2022, 2021 and 2020, as the issuance of shares upon conversion, exercise or vesting of outstanding units would be anti-dilutive in each period. There were 39,522 and 44,466 anti-dilutive shares outstanding as of March 31, 2022 and 2021, respectively. Accounting Pronouncements Recently Adopted As of January 1, 2022, the Company adopted ASU 2019-12 - Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (ASU 2019-12) . ASU 2019-12 attempts to simplify aspects of accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The adoption of ASU 2019-12 did not have a material effect on the Company’s unaudited condensed consolidated financial statements. As of January 1, 2022, the Company adopted ASU 2020-01 - Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) . The new standard clarifies the interaction of accounting for the transition into and out of the equity method. The new standard also clarifies the accounting for measuring certain purchased options and forward contracts to acquire investments. The adoption of ASU 2020-01 did not have a material effect on the Company’s unaudited condensed consolidated financial statements. As of January 1, 2022, the Company adopted ASU 2021-04 - Earnings Per Share (Topic 260), Debt - Modifications and Extinguishments (Topic 470-50), Compensation - Stock Compensation (Topic 718), and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40) , which clarifies existing guidance for freestanding written call options which are equity classified and remain so after they are modified or exchanged in order to reduce diversity in practice. The standard applies prospectively to modifications or exchanges that occur after it is adopted. The adoption of ASU 2021-04 did not have a material effect on the Company’s unaudited condensed consolidated financial statements. Accounting Pronouncements Not Yet Adopted In June 2016, the FASB issued ASU 2016-13 - Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”) , which was subsequently revised by ASU 2018-19 and ASU 2020-02. The ASU introduces a new model for assessing impairment on most financial assets. Entities will be required to use a forward-looking expected loss model, which will replace the current incurred loss model, which will result in earlier recognition of allowance for losses. The ASU will be effective for the Company’s first interim period of fiscal 2023. The Company continues to evaluate the impact of this ASU on its unaudited condensed consolidated financial statements. In October 2021, the FASB issued ASU 2021-08 - Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The new standard improves the accounting for acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency. The new standard requires an entity to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with ASC 606 - Revenue from Contracts with Customers . The ASU will be effective for the Company’s first interim period of fiscal 2024. The standard should be applied prospectively to business combinations occurring on or after the effective date of the amendments. The Company does not anticipate a material impact on the Company’s unaudited condensed consolidated financial statements upon adoption.

ACQUISITIONS, DIVESTITURES AND

ACQUISITIONS, DIVESTITURES AND ASSETS HELD FOR SALE	3 Months Ended
	Mar. 31, 2022
Business Combinations, Discontinued Operations And Disposal Groups [Abstract]
ACQUISITIONS, DIVESTITURES AND ASSETS HELD FOR SALE	ACQUISITIONS, DIVESTITURES AND ASSETS HELD FOR SALE Acquisitions During the three month period ended March 31, 2022, the Company did not complete any business combinations. During the year ended December 31, 2021, the Company completed the following business combinations, and has allocated the purchase price as follows: Purchase Price Allocation CWG Greenleaf Total Assets acquired: Cash and cash equivalents $ 828 $ 1,209 $ 2,037 Inventory 1,200 2,692 3,892 Other current assets 347 1,520 1,867 Capital assets, net 3,312 22,923 26,235 Operating lease right-of-use asset 1,584 2,819 4,403 Goodwill 1,482 18,619 20,101 Intangible assets, net - cannabis licenses 3,200 — 3,200 Intangible assets, net - customer relationships 1,000 — 1,000 Other non-current assets 40 189 229 Liabilities assumed: Accounts payable and accrued liabilities (464) (1,829) (2,293) Taxes payable (68) (33) (101) Operating lease liability, current (193) (315) (508) Other current liabilities 3 (294) (291) Operating lease liability, non-current (1,391) (2,504) (3,895) Fair value of net assets acquired $ 10,880 $ 44,996 $ 55,876 Consideration paid: Settlement of pre-existing relationship 10,880 44,996 $ 55,876 Total consideration $ 10,880 $ 44,996 $ 55,876 CWG On April 30, 2021, a subsidiary of the Company acquired 100% of CWG Botanicals, Inc. (“CWG”), an adult-use cannabis cultivation and processing operations in the state of California. The completion of this acquisition expanded the Company’s footprint in California. The consideration paid for CWG consisted of the settlement of a pre-existing relationship, which included a line of credit of $9,321 and the related interest receivable of $1,559, which were both previously recorded in Notes receivable, non-current on the Statements of Financial Position. The purchase price allocation is based upon final valuations within the measurement period (generally one year from the acquisition date). Greenleaf On October 1, 2021, a subsidiary of the Company acquired of 100% of Greenleaf Apothecaries (“GLA”), Greenleaf Gardens (“GLG”), and Greenleaf Therapeutics (“GLT”), collectively known as “Greenleaf.” Greenleaf consists of cannabis cultivation, processing, and dispensary operations in the state of Ohio. The completion of this acquisition established Acreage’s footprint in the Ohio cannabis market. On July 2, 2018, the Company entered into purchase agreements for Greenleaf for the total purchase price of approximately $8,245 in cash, $6,096 in seller notes payable and 1.2 million shares of HSCP with an average fair value of $7.73 per share, which are convertible into shares of the Company. In addition, the Company extended a $31,200 line of credit and issued $12,500 in promissory notes to the Greenleaf entities. The consideration paid was made in exchange for: (a) the rights to acquire the Greenleaf entities upon state regulatory approval and; (b) master services agreements (“MSAs”) to operate the entities until such approval was granted and ownership interests were transferred. The purchase consideration paid represents the fair value of the intangible asset related to the MSA that was recorded on the Company’s Statement of Financial Position at the time of the transaction. The intangible asset was amortized over the life of the MSAs. Upon closing, the Company repaid the remaining $3,300 worth of sellers notes payable and accrued interest and assumed $42,043 in notes and interest receivable owed to the Company by Greenleaf that was eliminated upon consolidation. Total consideration for the asset transfer transaction was $44,996, representing the sum of the $2,953 carrying value of intangible assets from the 2018 transaction and the liabilities assumed. As the Company owns 100% of Greenleaf, the subsidiary is accounted for on a consolidated basis as of the closing date. The purchase price allocation is based upon preliminary valuations and estimates and assumptions which are subject to change within the measurement period, generally one year from the acquisition date. The primary areas of the purchase price allocation that are not yet finalized relate to the valuation of the tangible and intangible assets acquired and the residual goodwill resulting from the transaction. NCCRE On March 19, 2021, a subsidiary of the Company, HSC Solutions, LLC (“HSC Solutions”) entered into an assignment of membership agreement to acquire the remaining non-controlling interests of its subsidiary, NCC Real Estate, LLC (“NCCRE”), based primarily on the fair value of property held by NCCRE estimated in the amount of $850. The consideration paid to the non-controlling interest sellers of $286 was recorded in Additional paid-in capital and Non-controlling interests on the Statements of Financial Position. Additionally, the Company subsequently repaid the outstanding principal balance of the NCCRE secured loan. Divestitures During the three months ended March 31, 2022 and 2021, the Company did not complete any divestitures. Assets Held for Sale The Company determined certain businesses and assets met the held-for-sale criteria. Upon classification of the disposal groups as held for sale, the Company tested each disposal group for impairment and recognized charges (recovery) of $874 for the three months ended March 31, 2022 related to the Oregon disposal group and $(8,616) for the three months ended March 31, 2021 related to the Acreage Florida disposal group within Write down (recovery) of assets held-for-sale on the Unaudited Condensed Consolidated Statements of Operations. Additionally, all assets and liabilities determined within these disposal groups were transferred into Assets held-for-sale and Liabilities related to assets held for sale on the Unaudited Condensed Consolidated Statements of Financial Position as of March 31, 2022 and December 31, 2021. Furthermore, the Company was unsuccessful in finding a satisfactory buyer for all of its Michigan locations. As a result, the assets remaining in Michigan no longer meet the criteria for being classified as held-for sale and have been impaired (refer to Note 7 for further discussion). The tables below present the preliminary fair values of the assets and liabilities classified as held for sale on the Unaudited Condensed Consolidated Statements of Financial Position for the years ended March 31, 2022 and December 31, 2021, respectively, and are subject to change based on developments during the sales process. March 31, 2022 Oregon (1) Cash $ 347 Accounts receivable, net 140 Inventory 309 Other current assets 4 Total current assets classified as held-for-sale 800 Capital assets, net 1,673 Operating lease right-of-use assets 1,556 Goodwill 2,191 Non-current assets 91 Total assets classified as held for sale $ 6,311 Accounts payable and accrued liabilities $ (564) Operating lease liability, current (434) Total current liabilities classified as held-for-sale (998) Operating lease liability, non-current (671) Total liabilities classified as held-for-sale $ (1,669) (1) In February 2021, a subsidiary of the Company entered into a definitive agreement and management services agreement to sell an indoor cultivation facility in Medford, Oregon and a retail dispensary in Portland, Oregon, for total consideration of $3,000, to be paid in a series of tranches based on estimated regulatory approvals which are not expected to exceed 18 months. In March 2022, the total consideration was reduced to $2,000. Additionally, in September 2021, a subsidiary of the Company entered into a definitive agreement and management services agreements to sell, upon regulatory approval, four retail dispensaries in Oregon for total consideration of $6,500, consisting of a $250 cash payment at the time of signing and a 10-month secured promissory note. December 31, 2021 Michigan (1) Oregon Total Cash $ — $ 223 $ 223 Inventory — 445 445 Notes receivable, current — 31 31 Other current assets — 9 9 Total current assets classified as held-for-sale — 708 708 Capital assets, net 1,907 2,342 4,249 Operating lease right-of-use assets — 1,695 1,695 Goodwill — 2,191 2,191 Non-current assets — 109 109 Total assets classified as held for sale $ 1,907 $ 7,045 $ 8,952 Accounts payable and accrued liabilities $ — $ (639) $ (639) Operating lease liability, current — (441) (441) Total current liabilities classified as held-for-sale — (1,080) (1,080) Operating lease liability, non-current — (787) (787) Total liabilities classified as held-for-sale $ — $ (1,867) $ (1,867) (1) As of December 31, 2021, the Company was unsuccessful in finding a satisfactory buyer for certain of its Michigan locations. As a result, the assets at these specific locations no longer meet the criteria for being classified as held-for-sale.

INTANGIBLE ASSETS AND GOODWILL

INTANGIBLE ASSETS AND GOODWILL	3 Months Ended
	Mar. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
INTANGIBLE ASSETS AND GOODWILL	INTANGIBLE ASSETS AND GOODWILL Intangible assets The following table details the intangible asset balances by major asset classes: Intangibles March 31, 2022 December 31, 2021 Finite-lived intangible assets: Management contracts $ 1,808 $ 1,511 Customer relationships 1,000 1,000 2,808 2,511 Accumulated amortization on finite-lived intangible assets: Management contracts (639) (493) Customer relationships (550) — (1,189) (493) Finite-lived intangible assets, net 1,619 2,018 Indefinite-lived intangible assets Cannabis licenses 117,080 117,677 Total intangibles, net $ 118,699 $ 119,695 The intangible assets balance as of March 31, 2022 and December 31, 2021 excludes intangible assets reclassified to assets held-for-sale (refer to Note 3 for further discussion). The average useful life of finite-lived intangible assets ranges from 0.8 to 2.0 years, with 0.8 and 2.0 years being the average useful life for customer relationships and management contracts, respectively. Impairment of intangible assets The Company assessed whether any events or changes in circumstances ("triggering events") indicated finite-lived intangible assets to be held-and-used would not be recovered. During the three months ended March 31, 2022, the Company did not identify any triggering events. During the three months ended March 31, 2021, the Company identified a triggering event for its management contract owned by Prime Alternative Treatment Center Consulting, LLC ("PATCC"). The Company evaluated the recoverability of the asset by comparing the carrying value of the asset to the future net undiscounted cash flows expected to be generated by the asset. The carrying value was determined to not be recoverable and the Company proceeded to test the asset for impairment. The Company recognized an impairment charge of $818 due to changes in expected cash flows pursuant to a revised consulting services agreement. These charges are recognized in Impairments, net on the Unaudited Condensed Consolidated Statements of Operations. The impairment resulted in the recognition of a tax provision benefit and an associated reversal of deferred tax liabilities of $205 during the three months ended March 31, 2021. Amortization expense recorded during the three months ended March 31, 2022 and 2021 was $696 and $541, respectively. Expected annual amortization expense for existing intangible assets subject to amortization at March 31, 2022 is as follows for each of the next five fiscal years: Amortization of Intangibles 2022 2023 2024 2025 2026 Amortization expense $ 889 $ 585 $ 145 $ — $ — Goodwill The following table details the changes in the carrying amount of goodwill: Goodwill Total December 31, 2021 $ 43,310 Other Adjustments (1) 224 March 31, 2022 $ 43,534 (1) Represents adjustments related to the remeasurement of certain deferred tax assets and related adjustments within the measurement period.

INVESTMENTS

INVESTMENTS	3 Months Ended
	Mar. 31, 2022
Investments [Abstract]
INVESTMENTS	INVESTMENTS The carrying values of the Company’s investments in the Unaudited Condensed Consolidated Statements of Financial Position as of March 31, 2022 and December 31, 2021 are as follows: Investments March 31, 2022 December 31, 2021 Total short-term investments $ 3,401 $ — Investments held at FV-NI 36,014 35,226 Total long-term investments $ 36,014 $ 35,226 Income (loss) from investments, net in the Unaudited Condensed Consolidated Statements of Operations during the three months ended March 31, 2022 and 2021 is as follows: Investment income (loss) Three Months Ended March 31, 2022 2021 Short-term investments $ 1 $ — Investments held at FV-NI 1,132 (144) Income (loss) from investments, net $ 1,133 $ (144) Short-term investments During the three months ended March 31, 2022, the Company made an investment in a Canadian guaranteed investment certificate (“GIC”) which bears an interest rate of 0.2% and has an original maturity of 1 year. GIC’s are a deposit investment generally sold by Canadian banks. Investments held at FV-NI The Company has investments in equity of several companies that do not result in significant influence or control. These investments are carried at fair value, with gains and losses recognized in the Unaudited Condensed Consolidated Statements of Operations. As further described under the “6.10% Secured debenture due September 2030” in Note 10, on September 23, 2020, a subsidiary of the Company, Universal Hemp, LLC ("Universal Hemp") was advanced gross proceeds of $50,000 (less transaction costs) pursuant to the terms of a secured debenture. The Company subsequently engaged an investment advisor, which under the investment advisor's sole discretion, on September 28, 2020 invested $34,019 of these proceeds on behalf of Universal Hemp. As a result, Universal Hemp acquired 34,019 class B units, at $1 par value per unit, which represented 100% financial interest in an Investment Partnership, a Canada-based limited partnership. An affiliate of the Institutional Investor holds Class A units of the Investment Partnership. The general partner of the Investment Partnership is also an affiliate of the Institutional Investor. The Class B units are held by the Investment Advisor as an agent for Universal Hemp.

NOTES RECEIVABLE

NOTES RECEIVABLE	3 Months Ended
	Mar. 31, 2022
Receivables [Abstract]
NOTES RECEIVABLE	NOTES RECEIVABLE Notes receivable as of March 31, 2022 and December 31, 2021 consisted of the following: March 31, 2022 December 31, 2021 Promissory notes receivable $ 27,262 $ 27,260 Line of credit receivable 7,551 12,609 Interest receivable 3,300 2,834 Allowance for notes and interest receivables (8,258) (8,036) Total notes receivable $ 29,855 $ 34,667 Less: Notes receivable, current 2,222 7,104 Notes receivable, non-current $ 27,633 $ 27,563 Interest income on notes receivable during the three months ended March 31, 2022 and 2021 totaled $417 and $1,465, respectively. The Company determined that the collectability of certain notes receivables is doubtful based on information available. As of March 31, 2022 and December 31, 2021, the Company’s allowance for notes receivable of $8,258 and $8,036, respectively, included $6,046 of principal outstanding for both periods and $2,212 and $1,990 of accrued interest, respectively, and represents the full value of such loan balances. Activity during the three months ended March 31, 2022 On February 10, 2022, the Company received a $5,279 cash payment in full on a line of credit due from Patient Centric Martha’s Vineyard (“PCMV”), and subsequently closed the line of credit. Activity during the three months ended March 31, 2021 In March 2021, the Company entered into a revised consulting services and line of credit agreement with PATCC, whereby previously unrecognized management fees were settled for $2,500, which was recognized in Other revenue, net on Unaudited Condensed Consolidated Statements of Operations during the three months ended March 31, 2021. Pursuant to the revised line of credit agreement, the line of credit is non-interest bearing and will be repaid on a payment schedule with seven payments in the aggregate amount of $7,150 through June 2023.

CAPITAL ASSETS, net

CAPITAL ASSETS, net	3 Months Ended
	Mar. 31, 2022
Property, Plant and Equipment [Abstract]
CAPITAL ASSETS, net	CAPITAL ASSETS, net Net property, plant and equipment consisted of: March 31, 2022 December 31, 2021 Land $ 3,758 $ 3,777 Building 57,935 43,921 Right-of-use asset, finance leases 10,865 5,077 Construction in progress 17,866 7,644 Furniture, fixtures and equipment 31,590 31,325 Leasehold improvements 39,656 51,646 Capital assets, gross $ 161,670 $ 143,390 Less: accumulated depreciation (19,602) (16,593) Capital assets, net $ 142,068 $ 126,797 Depreciation of capital assets for the three months ended March 31, 2022 and 2021 is comprised of $1,111 and $428 of depreciation expense, and $1,922 and $911 that was capitalized to inventory, respectively. During the three months ended March 31, 2022 the Company determined that it was unable to find a satisfactory buyer for the held-for-sale assets related to its Michigan operations and, as such, these assets were reclassified as held-and-used. This conclusion was considered a triggering event for capital asset impairment testing. Upon assessment, these specific capital assets were not considered to have future economic value. As such, the fair value of the assets was considered to be nil and the Company recognized an impairment charge of $1,907 within Impairments, net on the Statements of Operations during the three months ended March 31, 2022. Refer to Note 3 for further discussion on changes in held-for-sale entities.

LEASES

LEASES	3 Months Ended
	Mar. 31, 2022
Leases [Abstract]
LEASES	LEASES The Company leases land, buildings, equipment and other capital assets which it plans to use for corporate purposes in addition to the production and sale of cannabis products. Leases with an initial term of 12 months or less are not recorded on the Unaudited Condensed Consolidated Statements of Financial Position and are expensed in the Unaudited Condensed Consolidated Statements of Operations on the straight-line basis over the lease term. The Company does not have any material variable lease payments, and accounts for non-lease components separately from leases. Balance Sheet Information Classification March 31, 2022 December 31, 2021 Right-of-use assets Operating Operating lease right-of-use assets $ 24,571 $ 24,598 Finance Capital assets, net 10,246 4,522 Total right-of-use assets $ 34,817 $ 29,120 Lease liabilities Current Operating Operating lease liability, current $ 2,343 $ 2,145 Financing Debt, current 5,786 — Non-current Operating Operating lease liability, non-current 24,146 24,255 Financing Debt, non-current 5,257 5,245 Total lease liabilities $ 37,532 $ 31,645 Statement of Operations Information Classification Three Months Ended March 31, 2022 Three Months Ended Short-term lease expense General and administrative $ 48 $ 88 Operating lease expense General and administrative 1,248 1,046 Finance lease expense: Amortization of right of use asset Depreciation and amortization 63 63 Interest expense on lease liabilities Interest expense 212 184 Sublease income Other income (loss), net — (3) Net operating and finance lease cost $ 1,523 $ 1,290 Statement of Cash Flows Information Classification Three Months Ended Three Months Ended Cash paid for operating leases Net cash used in operating activities $ 1,257 $ 1,437 Cash paid for finance leases - interest Net cash used in operating activities $ 201 $ 169 The following represents the Company’s future minimum payments required under existing leases with initial terms of one year or more as of March 31, 2022: Maturity of lease liabilities Operating Leases (1) Finance Leases 2022 $ 3,763 $ 6,500 2023 4,823 722 2024 4,537 743 2025 4,554 766 2026 4,453 789 Thereafter 20,470 12,486 Total lease payments $ 42,600 $ 22,006 Less: interest 15,006 10,963 Present value of lease liabilities $ 27,594 $ 11,043 Weighted average remaining lease term (years) 8 2 Weighted average discount rate 9% 10% (1) Includes minimum payments under existing operating leases currently classified as held-for-sale (refer to Note 3 for further discussion). As of March 31, 2022, the Company entered into three lease agreements that have not yet commenced. The Company will determine the classifications at the respective commencement dates for the leases, but currently expect all of the leases to be classified as operating leases. The lease terms range from five
LEASES	LEASES The Company leases land, buildings, equipment and other capital assets which it plans to use for corporate purposes in addition to the production and sale of cannabis products. Leases with an initial term of 12 months or less are not recorded on the Unaudited Condensed Consolidated Statements of Financial Position and are expensed in the Unaudited Condensed Consolidated Statements of Operations on the straight-line basis over the lease term. The Company does not have any material variable lease payments, and accounts for non-lease components separately from leases. Balance Sheet Information Classification March 31, 2022 December 31, 2021 Right-of-use assets Operating Operating lease right-of-use assets $ 24,571 $ 24,598 Finance Capital assets, net 10,246 4,522 Total right-of-use assets $ 34,817 $ 29,120 Lease liabilities Current Operating Operating lease liability, current $ 2,343 $ 2,145 Financing Debt, current 5,786 — Non-current Operating Operating lease liability, non-current 24,146 24,255 Financing Debt, non-current 5,257 5,245 Total lease liabilities $ 37,532 $ 31,645 Statement of Operations Information Classification Three Months Ended March 31, 2022 Three Months Ended Short-term lease expense General and administrative $ 48 $ 88 Operating lease expense General and administrative 1,248 1,046 Finance lease expense: Amortization of right of use asset Depreciation and amortization 63 63 Interest expense on lease liabilities Interest expense 212 184 Sublease income Other income (loss), net — (3) Net operating and finance lease cost $ 1,523 $ 1,290 Statement of Cash Flows Information Classification Three Months Ended Three Months Ended Cash paid for operating leases Net cash used in operating activities $ 1,257 $ 1,437 Cash paid for finance leases - interest Net cash used in operating activities $ 201 $ 169 The following represents the Company’s future minimum payments required under existing leases with initial terms of one year or more as of March 31, 2022: Maturity of lease liabilities Operating Leases (1) Finance Leases 2022 $ 3,763 $ 6,500 2023 4,823 722 2024 4,537 743 2025 4,554 766 2026 4,453 789 Thereafter 20,470 12,486 Total lease payments $ 42,600 $ 22,006 Less: interest 15,006 10,963 Present value of lease liabilities $ 27,594 $ 11,043 Weighted average remaining lease term (years) 8 2 Weighted average discount rate 9% 10% (1) Includes minimum payments under existing operating leases currently classified as held-for-sale (refer to Note 3 for further discussion). As of March 31, 2022, the Company entered into three lease agreements that have not yet commenced. The Company will determine the classifications at the respective commencement dates for the leases, but currently expect all of the leases to be classified as operating leases. The lease terms range from five

INVENTORY

INVENTORY	3 Months Ended
	Mar. 31, 2022
Inventory Disclosure [Abstract]
INVENTORY	INVENTORY The Company’s inventory balance consists of the following: March 31, 2022 December 31, 2021 Retail inventory $ 3,630 $ 3,331 Wholesale inventory 34,611 28,643 Cultivation inventory 6,988 6,367 Supplies & other 3,469 3,463 Total $ 48,698 $ 41,804

DEBT

DEBT	3 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
DEBT	DEBT The Company’s debt balances consist of the following: Debt balances March 31, 2022 December 31, 2021 Financing liability (failed sale-leaseback) $ 15,253 $ 15,253 Finance lease liabilities 11,043 5,245 7.50% Loan due April 2026 30,893 30,763 6.10% Secured debenture due September 2030 46,162 46,050 Note due December 2024 4,750 4,750 9.75% Credit facilities due January 2026 68,551 68,673 Total debt $ 176,652 $ 170,734 Less: current portion of debt 7,370 1,583 Total long-term debt $ 169,282 $ 169,151 Scheduled maturities of debt, excluding amortization of discount and issuance costs, are as follows: 2022 $ 7,321 2023 1,583 2024 1,584 2025 — 2026 108,011 Thereafter 70,547 Total payments (excluding amortization of discount and issuance costs) $ 189,046 During the three months ended March 31, 2022 and 2021, the Company incurred interest expense of $4,781 and $4,857, respectively, on the Unaudited Condensed Consolidated Statements of Operations. Interest expense for the three months ended March 31, 2022 and 2021 included debt discount amortization of $373 and $260, respectively, and amortization of debt issuance costs of $266 and $852, respectively. As of March 31, 2022 and December 31, 2021, the Company had unamortized discount $5,821 and $6,320, respectively, and debt issuance costs of $6,573 and $6,194, respectively, which is netted against the gross carrying value of long-term debt in Debt, non-current on Unaudited Condensed Unaudited Condensed Consolidated Statements of Financial Position. Additionally, as of March 31, 2022 and December 31, 2021, the Company had accrued interest of $2,562 and $1,432, respectively, within Interest payable on the Unaudited Condensed Consolidated Statements of Financial Position. Financing liability (failed sales leaseback) In connection with the Company’s failed sale-leaseback transaction (refer to Note 7 for further discussion), a financing liability was recognized equal to the cash proceeds received. The Company will recognize the cash payments made on the lease as interest expense, and the principal will be de-recognized upon expiration of the lease. 6.10% Secured debenture due September 2030 On September 23, 2020, pursuant to the implementation of the Amended Arrangement (Refer to Note 13 for further discussion), a subsidiary of Canopy Growth advanced gross proceeds of $50,000 (less transaction costs of approximately $4,025) to Universal Hemp, an affiliate of the Company, pursuant to the terms of a secured debenture (“6.1% Loan”). In accordance with the terms of the debenture, the funds cannot be used, directly or indirectly, in connection with or for any cannabis or cannabis-related operations in the United States, unless and until such operations comply with all applicable laws of the United States. An additional $50,000 may be advanced pursuant to the debenture subject to the satisfaction of certain conditions by Universal Hemp. The debenture bears interest at a rate of 6.1% per annum, matures 10 years from the date hereof or such earlier date in accordance with the terms of the debenture and all interest payments made pursuant to the debenture are payable in cash by Universal Hemp. The debenture is not convertible and is not guaranteed by Acreage. With a portion of the proceeds for the 6.1% Loan received by Universal Hemp, Acreage engaged an Investment Advisor which, under the Investment Advisor’s sole discretion, invested on behalf of Universal Hemp $34,019 on September 28, 2020. As a result, Universal Hemp acquired 34,019 class B units, at $1.00 par value per unit, which represented 100% financial interest in the Investment Partnership, a Canada-based limited partnership. An affiliate of the Institutional Investor holds class A units of the Investment Partnership. The general partner of the Investment Partnership is also an affiliate of the Institutional Investor. The class B units are held by the Investment Advisor as an agent for Universal Hemp. Upon execution of the limited partnership agreement, $1,019 was distributed to the class A unit holders of the Investment Partnership. 7.50% Loan due April 2026 On September 28, 2020, the Company received gross proceeds of $33,000 (less transaction costs of approximately $959) from an affiliate of the Institutional Investor (the “Lender”) and used a portion of the proceeds of this loan to retire its short-term $11,000 convertible note (as described above) and its short-term note aggregating approximately $18,000 in October 2020, with the remainder being used for working capital purposes. The loan is unsecured, matures in 3 years and bears interest at a 7.5% annual interest rate. The Lender is controlled by the Institutional Investor. The Investment Partnership is the investor in the Lender. On December 16, 2021, the Company paid an amendment fee of $413 to extend the maturity date from September 28, 2023 to April 2, 2026. The amendment was treated as a debt extinguishment. Note due December 2024 In November 2020, the Company issued a promissory note with a third party, which is non-interest bearing and payable based on a payment schedule with ten payments in the aggregate amount of $7,750 through December 31, 2024, as a result of a settlement described under the “CanWell Dispute” in Note 13. 9.75% Credit facilities due January 2026 On December 16, 2021 the Company entered into a $150,000 senior secured credit facility with a syndicate of lenders consisting of a $75,000 initial draw, a $25,000 delayed draw that must be advanced within 12 months and a $50,000 committed accordion facility that is available after December 1, 2022, provided certain financial covenants are met, and with a maturity of January 1, 2026. Upon closing, gross proceeds of $75,000 were drawn (before origination discounts and issuance costs of approximately $4,000 and $1,500, respectively, which were capitalized). The loan is secured by pledged equity interests and substantially all of the assets of the Company. Advances under the facility bear interest at 9.75% per annum (plus an additional 1.0% per annum until certain collateral assignment agreements are delivered) and undrawn amounts (excluding the committed accordion facility until it is available) bear interest at 3.0% per annum. The loan is subject to various financial covenants, including a fixed charge coverage ratio and two leverage ratios. The Company has obtained a waiver of these covenants for the three month periods ended March 31, 2022 and June 30, 2022. This waiver included a $500 waiver fee that was paid to the lenders. Commencing with the receipt of the of the loan, mandatory prepayments are required from net proceeds of certain sale or disposition activities provided these proceeds are not invested in additional capital assets within 12 months of the disposition date, as defined by the Credit Agreement. As of March 31, 2022, the $25,000 delayed draw was not drawn upon. Refer to Note 14 for further discussion of the syndicated related party lender.

SHAREHOLDERS_ EQUITY AND NON-CO

SHAREHOLDERS’ EQUITY AND NON-CONTROLLING INTERESTS	3 Months Ended
	Mar. 31, 2022
Equity [Abstract]
SHAREHOLDERS’ EQUITY AND NON-CONTROLLING INTERESTS	SHAREHOLDERS’ EQUITY AND NON-CONTROLLING INTERESTS The table below details the change in Pubco shares outstanding by class for the three months ended March 31, 2022: Shareholders’ Equity Fixed Shares Floating Shares Fixed Shares Held in Treasury Floating Shares Held in Treasury Fixed Multiple Shares Total Shares Outstanding December 31, 2021 74,665 32,962 (589) (253) 118 106,903 Issuances 255 253 — — — 508 March 31, 2022 74,920 33,215 (589) (253) 118 107,411 Warrants A summary of the warrants activity outstanding is as follows: Warrants Fixed Shares Floating Shares December 31, 2021 5,817 2,524 Expired — — March 31, 2022 5,817 2,524 The exercise price of each Fixed and Floating Share warrant is $3.15 and $3.01, respectively. The warrants are exercisable for a period of 4 years. The weighted-average remaining contractual life of the warrants outstanding is approximately 2.9 years. There was no aggregate intrinsic value for warrants outstanding as of March 31, 2022. Non-controlling interests - convertible units The Company has NCIs in consolidated subsidiaries USCo2 and HSCP. The non-voting shares of USCo2 and HSCP units make up substantially all of the NCI balance as of March 31, 2022 and are convertible for either 0.7 of a Fixed Share and 0.3 of a Floating Share of Pubco or cash, as determined by the Company. Summarized financial information of HSCP is presented below. USCo2 does not have discrete financial information separate from HSCP. HSCP net asset reconciliation March 31, 2022 December 31, 2021 Current assets $ 103,620 $ 113,011 Non-current assets 391,449 375,807 Current liabilities (38,437) (29,256) Non-current liabilities (195,686) (195,791) Other NCI balances (718) (718) Accumulated equity-settled expenses (230,756) (226,596) Net assets $ 29,472 $ 36,457 HSCP/USCo2 ownership % of HSCP 17.18 % 17.24 % Net assets allocated to USCo2/HSCP $ 5,063 $ 6,285 Net assets attributable to other NCIs 718 718 Total NCI $ 5,781 $ 7,003 Three Months Ended March 31, HSCP Summarized Statement of Operations 2022 2021 Net loss allocable to HSCP/USCo2 $ (7,080) $ (4,549) HSCP/USCo2 weighted average ownership % of HSCP 17.21 % 18.40 % Net loss allocated to HSCP/USCo2 $ (1,218) $ (837) Net loss allocated to other NCIs 1 4 Net loss attributable to NCIs $ (1,217) $ (833) As of March 31, 2022, USCo2’s non-voting shares owned approximately 0.51% of HSCP units. USCo2’s capital structure is comprised of voting shares (approximately 71.33%), all of which are held by the Company, and of non-voting shares (approximately 28.67%) held by certain former HSCP members. Certain executive employees and profits interests holders own approximately 16.67% of HSCP units. The remaining 82.82% interest in HSCP is held by USCo and represents the members’ equity attributable to shareholders of the parent. During the three months ended March 31, 2021, the Company had several transactions with HSCP and USCo2 that changed its ownership interest in the subsidiaries but did not result in loss of control. These transactions included business acquisitions and the redemption of HSCP and USCo2 convertible units for Pubco shares (as shown in the table below), and resulted in a $(601) allocation from NCI to shareholders' equity for the three months ended March 31, 2021. A reconciliation of the beginning and ending amounts of convertible units is as follows: Three Months Ended March 31, Convertible Units 2022 2021 Beginning balance 23,076 24,142 Vested LLC C-1s canceled — — LLC C-1s vested — — NCI units converted to Pubco — (400) Ending balance 23,076 23,742

EQUITY-BASED COMPENSATION EXPEN

EQUITY-BASED COMPENSATION EXPENSE	3 Months Ended
	Mar. 31, 2022
Share-based Payment Arrangement [Abstract]
EQUITY-BASED COMPENSATION EXPENSE	EQUITY-BASED COMPENSATION EXPENSE Amended Arrangement with Canopy Growth On September 23, 2020, the Company announced the implementation of the Amended Arrangement (as defined in Note 13). Pursuant to the Amended Arrangement, the Company’s articles have been amended to create new Fixed Shares, Floating Shares and Fixed Multiple Shares. Consequently, the Company’s equity-based compensation was modified into new equity awards of the Company. Refer to Note 13 for further discussion. Equity-based compensation - Plan (Acreage Holdings, Inc. Omnibus Incentive Plan) In connection with the RTO transaction, the Company’s Board of Directors adopted an Omnibus Incentive Plan, as amended September 23, 2020 (the “Plan”), which permits the issuance of stock options, stock appreciation rights, stock awards, share units, performance shares, performance units and other stock-based awards up to an amount equal to 15% of the issued and outstanding Subordinate Voting Shares of the Company. Pursuant to the Amended Arrangement, the Company retained the Plan described above, the upper limit of issuances being up to an amount equal to 15% of the issued and outstanding Fixed Shares and Floating Shares of the Company. As of March 31, 2022, the Company had 11,595 shares authorized and available for grant under the Plan. Restricted Share Units (“RSUs”) Fixed Shares Floating Shares Restricted Share Units (Fair value information expressed in whole dollars) RSUs Weighted Average Grand Date Fair Value RSUs Weighted Average Grand Date Fair Value Unvested, January 1, 2022 3,188 $ 7.30 1,262 $ 7.39 Granted 28 $ 1.35 95 $ 1.19 Forfeited (177) $ 2.55 (21) $ 2.47 Vested (841) $ 8.81 (395) $ 8.00 Unvested, March 31, 2022 2,198 $ 7.03 941 $ 6.62 Vested and unreleased (1) 718 $ 10.70 310 $ 10.37 Outstanding, March 31, 2022 2,916 $ 7.94 1,251 $ 7.55 (1) RSUs that are vested and unreleased represent RSUs that are pending delivery. RSUs of the Company generally vest over a period of three years and RSUs granted to certain executives vest based on achievement of specific performance conditions. In certain situations for specified individuals, RSUs vest on an accelerated basis on separation. The fair value for RSUs is based on the Company’s share price on the date of the grant. The Company recorded $3,877 and $5,025 as Equity-based compensation expense on Unaudited Condensed Consolidated Statements of Operations during the three months ended March 31, 2022 and 2021, respectively. The fair value of RSUs vested during the three months ended March 31, 2022 and 2021 was $1,882 and $5,667, respectively. The total weighted average remaining contractual life and aggregate intrinsic value of unvested RSUs as of March 31, 2022 was approximately 1 year and $4,897, respectively. Unrecognized compensation expense related to these awards at March 31, 2022 was $12,340 and is expected to be recognized over a weighted average period of approximately 1 year. Stock options Fixed Shares Floating Shares Stock Options (Exercise price expressed in whole dollars) Options Weighted Average Exercise Price Options Weighted Average Exercise Price Options outstanding, January 1, 2022 1,529 $ 11.07 2,414 $ 3.06 Forfeited (4) $ 13.14 (1) $ 5.63 Options outstanding, March 31, 2022 1,525 $ 11.07 2,413 $ 3.06 Options exercisable, March 31, 2022 1,195 $ 13.06 1,894 $ 3.15 Stock options of the Company generally vest over a period of three years and options granted to certain executives vest based on achievement of specific performance conditions. Stock options of the Company have an expiration period of 5 or 10 years from the date of grant. The weighted average contractual life remaining for Fixed Share options outstanding and exercisable as of March 31, 2022 was approximately 6 and 7 years, respectively. The weighted average contractual life remaining for Floating Share options outstanding and exercisable as of March 31, 2022 was approximately 5 and 5 years, respectively. The Company recorded $282 and $1,017 as Equity-based compensation expense on Unaudited Condensed Consolidated Statements of Operations during the three months ended March 31, 2022 and 2021, respectively, in connection with these awards. As of March 31, 2022, unamortized expense related to stock options totaled $1,241 and is expected to be recognized over a weighted-average period of approximately 1 year. As of March 31, 2022, the aggregate intrinsic value for unvested options and for vested and exercisable options was nil, respectively.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIES Commitments The Company provides revolving lines of credit to several third parties. As of March 31, 2022, the maximum obligation under these arrangements was $15,150 (refer to Note 6 for further discussion). Prior Plan of Arrangement with Canopy Growth On June 19, 2019, the shareholders of the Company and of Canopy Growth separately approved the proposed plan of arrangement (the “Prior Plan of Arrangement”) involving the two companies, and on June 21, 2019, the Supreme Court of British Columbia granted a final order approving the Prior Plan of Arrangement. Effective June 27, 2019, the articles of the Company were amended pursuant to the Prior Plan of Arrangement to provide that, upon the occurrence (or waiver by Canopy Growth) of the Triggering Event, and subject to the satisfaction of the conditions set out in the arrangement agreement entered into between Acreage and Canopy Growth on April 18, 2019, as amended on May 15, 2019 (the “Original Arrangement Agreement”), Canopy Growth will acquire (the “Acquisition”) all of the issued and outstanding shares in the capital of the Company (each, an “Acreage Share”). Second Amendment to the Arrangement Agreement with Canopy Growth On September 23, 2020, Acreage and Canopy Growth entered into an amending agreement (the “Amending Agreement” or “Amended Arrangement”) (and together with the Original Arrangement Agreement and any further amendments thereto, the “Amended Plan of Arrangement”) and the Amended Arrangement became effective at 12:01 a.m. (Vancouver time) (the “Amendment Time”) on September 23, 2020 (the “Amendment Date”). Pursuant to the Amended Plan of Arrangement, Canopy Growth made a cash payment of $37,500 which was delivered to Acreage’s shareholders and certain holders of securities convertible or exchangeable into shares of Acreage. Acreage also completed a capital reorganization (the “Capital Reorganization”) effective as of the Amendment Time whereby: (i) each existing SVS was exchanged for 0.7 of a Fixed Share and 0.3 of a Floating Share; (ii) each issued and outstanding PVS was exchanged for 28 Fixed Shares and 12 Floating Shares; and (iii) each issued and outstanding MVS was exchanged for 0.7 of a Fixed Multiple Share and 0.3 of a Floating Share. At the Amendment Time, each option, restricted share unit, compensation option, and warrant to acquire existing SVS (each a “Security”) that was outstanding immediately prior to the Amendment Time was exchanged for a replacement Security to acquire Fixed Shares (a “Fixed Share Replacement Security”) or Floating Shares (a “Floating Share Replacement Security”) to account for the Capital Reorganization. Pursuant to the Amended Plan of Arrangement, upon the occurrence or waiver (at the discretion of Canopy Growth) of the Triggering Event (the “Triggering Event Date”), Canopy Growth will, subject to the satisfaction or waiver of certain closing conditions set out in the Amended Plan of Arrangement: (i) acquire all of the issued and outstanding Fixed Shares (following the mandatory conversion of the Fixed Multiple Shares into Fixed Shares) on the basis of 0.3048 of a common share of Canopy Growth (each whole common share, a “Canopy Growth Share”) for each Fixed Share held (the “Fixed Exchange Ratio”) at the time of the acquisition of the Fixed Shares (the “Acquisition Time”), subject to adjustment in accordance with the terms of the Amended Plan of Arrangement (the “Canopy Call Option”); and (ii) have the right (but not the obligation), exercisable for a period of 30 days following the Triggering Event Date to acquire all of the issued and outstanding Floating Shares (the “Floating Call Option”) at a price to be determined based upon the 30 day volume-weighted average trading price of the Floating Shares, subject to a minimum price of $6.41, as may be adjusted in accordance with the terms of the Amended Plan of Arrangement, to be payable, at the option of Canopy Growth, in cash, Canopy Growth Shares, or a combination thereof. If any portion is paid in Canopy Growth Shares, the number of Canopy Growth Shares to be exchanged for each Floating Share shall be determined on the basis of a 30 day volume-weighted average calculation using the Floating Shares (the “Floating Ratio”). The closing of the acquisition of the Floating Shares pursuant to the Floating Call Option, if exercised, will take place concurrently with the closing of the acquisition of the Fixed Shares pursuant to the Canopy Call Option, if exercised. The Canopy Call Option and the Floating Call Option will expire 10 years from the Amendment Date. At the Acquisition Time each Fixed Share Replacement Security will be exchanged for a replacement Security from Canopy Growth equal to: (i) the number of Fixed Shares that were issuable upon exercise of such Fixed Share Replacement Security immediately prior to the Acquisition Time, multiplied by (ii) the Fixed Exchange Ratio in effect immediately prior to the Acquisition Time (if the foregoing would result in the issuance of a fraction of a Canopy Growth Share, then the number of Shares to be issued would be rounded down to the nearest whole number). In the event that the Floating Call Option is exercised and Canopy Growth acquires the Floating Shares at the Acquisition Time, each Floating Share Replacement Security will be exchanged for a replacement Security from Canopy Growth equal to: (i) the number of Floating Shares that were issuable upon exercise of such Floating Share Replacement Security immediately prior to the Acquisition Time, multiplied by (ii) the Floating Ratio (if the foregoing would result in the issuance of a fraction of a Canopy Growth Share, then the number of Shares to be issued would be rounded down to the nearest whole number). In the event that the Floating Call Option is exercised and Canopy Growth acquires the Floating Shares at the Acquisition Time, Acreage will be a wholly-owned subsidiary of Canopy Growth. The Amended Plan of Arrangement provides for, among other things, Amendments to the definition of Purchaser Approved Share Threshold (as defined therein) to change the number of Acreage shares available to be issued by Acreage without an adjustment in the Fixed Exchange Ratio such that Acreage may issue a maximum of 32,700 shares. Furthermore, Acreage generally may not issue any equity securities without Canopy Growth’s prior consent. Additionally, the Amended Plan of Arrangement allows for various Canopy Growth rights that extend beyond the Acquisition Date, including, among others, (i) rights to nominate a majority of Acreage’s Board of Directors following the Acquisition Time; (ii) restrictive covenants in respect of the business conduct in favor of Canopy Growth; (iii) termination of non-competition and exclusivity rights granted to Acreage by Canopy Growth in the event that Acreage does not meet certain specified financial targets; (iv) implementation of further restrictions on Acreage’s ability to operate its business in the event that Acreage does not meet certain specified financial targets; and (v) termination of the Amended Plan of Arrangement in the event that Acreage does not meet certain specified financial targets in the trailing 12 month period. Further, the Amended Plan of Arrangement imposes restrictions on Acreage entering into any contracts in respect of Company Debt if: (i) such contract would be materially inconsistent with market standards for companies operating in the United States cannabis industry; (ii) such contract prohibits a prepayment of the principal amount of such Company Debt; and (iii) such contract would provide for interest payments to be paid through the issuance of securities as opposed to cash, among other restrictions. The Amended Plan of Arrangement also provides for the following: (i) certain financial reporting obligations to Canopy; (ii) certain specified criteria related to any new directors or officers of Acreage, (iii) a limit to Acreage’s operations to the Identified States (as defined therein). Debenture In connection with the implementation of the Amended Arrangement, pursuant to a secured debenture dated September 23, 2020 (the “Debenture”) issued by Universal Hemp, LLC, an affiliate of Acreage that operates solely in the hemp industry in full compliance with all applicable laws (the “Borrower”), to 11065220 Canada Inc., an affiliate of Canopy Growth (the “Lender”), the Lender agreed to provide a loan of up to $100,000 (the “Loan”), $50,000 of which was advanced on the Amendment Date (the “Initial Advance”), and $50,000 of the Loan will be advanced in the event that the following conditions, among others, are satisfied: (a) the Borrower’s EBITDA (as defined in the Debenture) for any 90 day period is greater than or equal to 2.0 times the interest costs associated with the Initial Advance; and (b) the Borrower’s business plan for the 12 months following the applicable 90 day period supports an Interest Coverage Ratio (as defined in the Debenture) of at least 2.00:1. The principal amount of the Loan will bear interest from the date of advance, compounded annually, and be payable on each anniversary of the date of the Debenture in cash in U.S. dollars at a rate of 6.1% per annum. The Loan will mature 10 years from the date of the Initial Advance. The Loan must be used exclusively for U.S. hemp-related operations and on the express condition that such amount will not be used, directly or indirectly, in connection with or for the operation or benefit of any of the Borrower’s affiliates other than subsidiaries of the Borrower exclusively engaged in U.S. hemp-related operations and not directly or indirectly, towards the operation or funding of any activities that are not permissible under applicable law. The Loan proceeds must be segregated in a distinct bank account and detailed records of debits to such distinct bank account will be maintained by the Borrower. No payment due and payable to the Lender by the Borrower pursuant to the Debenture may be made using funds directly or indirectly derived from any cannabis or cannabis-related operations in the United States, unless and until the Triggering Event Date. The Debenture includes usual and typical events of default for a financing of this nature, including, without limitation, if: (i) Acreage is in breach or default of any representation or warranty in any material respect pursuant to the Arrangement Agreement; (ii) the Non-Core Divestitures are not completed within 18 months from the Amendment Date; and (iii) Acreage fails to perform or comply with any covenant or obligation in the Arrangement Agreement which is not remedied within 30 days after written notice is given to the Borrower by the Lender. The Debenture also includes customary representations and warranties, positive covenants and negative covenants of the Borrower. Surety bonds The Company has indemnification obligations with respect to surety bonds primarily used as security against non-performance in the amount of $5,000 as of March 31, 2022, for which no liabilities are recorded on the Unaudited Condensed Consolidated Statements of Financial Position. The Company is subject to other capital commitments and similar obligations. As of March 31, 2022 and 2021, such amounts were not material. CanWell Settlement In November 2020, the Company entered into a final confidential settlement agreement with CanWell, LLC for certain outstanding proceedings. As part of that agreement, the Company accrued for $7,750 in Legal settlements, net on the Statements of Operations for the year ended December 31, 2020. In connection with this settlement agreement, the Company issued a promissory note in the amount of $7,750 to CanWell, which is non-interest bearing and is payable in periodic payments through December 31, 2024. Through March 31, 2022, the Company has paid $3,000 of the promissory note. Contingencies The Company’s operations are subject to a variety of local and state regulations. Failure to comply with one or more of those regulations could result in fines, restrictions on its operations, or losses of permits that could result in the Company’s applicable subsidiaries ceasing operations. While management of the Company believes that the Company’s subsidiaries are in compliance with applicable local and state regulations as of March 31, 2022, cannabis regulations continue to evolve and are subject to differing interpretations. As a result, the Company’s subsidiaries may be subject to regulatory fines, penalties, or restrictions in the future. The Company and its subsidiaries may be, from time to time, subject to various administrative, regulatory and other legal proceedings arising in the ordinary course of business. Contingent liabilities associated with legal proceedings are recorded when a liability is probable, and the contingent liability can be reasonably estimated. New York outstanding litigation On November 2, 2018, EPMMNY LLC (“EPMMNY”) filed a complaint in the Supreme Court of the State of New York, County of New York, asserting claims against 16 defendants, including NYCANNA, Impire State Holdings LLC, NY Medicinal Research & Caring, LLC (each, a wholly-owned subsidiary of High Street) and High Street. The Index Number for the action is 655480/2018. EPMMNY alleges that it was wrongfully deprived of a minority equity interest and management role in NYCANNA by its former partner, New Amsterdam Distributors, LLC, which attempted to directly or indirectly sell or transfer EPMMNY’s alleged interest in NYCANNA to other entities in 2016 and 2017, including Impire, NYMRC and High Street. EPMMNY alleges that it is entitled to the value of its alleged minority interest in NYCANNA or minority ownership in NYCANNA. EPMMNY also alleges that certain defendants misused its alleged intellectual property and/or services, improperly solicited its employees, and aided and abetted or participated in the transfer of equity and/or business opportunities from EPMMNY. High Street intends to vigorously defend this action, which the Company firmly believes is without merit. High Street is also entitled to full indemnity from the claims asserted against it by EPMMNY pursuant to the purchase agreement pertaining to its acquisition of NYCANNA and personal guarantee by the largest shareholders of the seller. High Street, along with the other defendants filed a motion to dismiss on April 1, 2019. The motion was fully briefed and submitted to the Court as of July 18, 2019, and oral argument was heard on September 6, 2019. The motion remains pending before the Court. Following a hearing held the week of April 25-29, 2022, the Court ruled that Plaintiff had the capacity to bring this action on behalf of EPMMNY. The motions to dismiss remain pending on all other grounds. Compass Neuroceuticals Litigation In February 2021, a JAMS arbitration was initiated in Atlanta by Acreage Georgia LLC (“Acreage Georgia”) against its former consultant, Compass Neuroceuticals, Inc. (“Compass”), stemming from Compass’ breach of the consulting agreement entered into between the parties in June 2019, related to the preparation of an application for a Class 1 cultivation license in Georgia. Acreage Georgia is seeking approximately $1,000, plus attorney’s fees and costs. Compass has filed a counterclaim for breach in the $9,000 range. A final arbitration hearing took place from September 20 through September 24, in Atlanta, Georgia. On December 13, 2021, the arbitrator issued her interim award, finding in favor of the Company and denying Compass' counterclaim. A hearing took place on February 9, 2022 to determine the Company’s damages and attorney’s fees. On March 8, 2022, the arbitrator issued a final award of $694 to the Company. A contested action is currently pending in Forsyth County, Georgia seeking to confirm the arbitrator’s award.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	3 Months Ended
	Mar. 31, 2022
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	RELATED PARTY TRANSACTIONS Transactions with related parties are entered into in the normal course of business and are measured at the amount established and agreed to by the parties. Related party notes receivable Acreage has certain outstanding notes receivable with related parties. Refer to Note 6 for further discussion. In May 2021, the Company sold two secured promissory notes totaling $28,000 received from the sale of Acreage Florida to Viridescent for cash proceeds of approximately $26,000. Viridescent is an entity controlled by Kevin Murphy, the Chairman of the board of directors. Refer to Note 3 for further discussion. 6.10% Secured debenture due September 2030 As disclosed in Note 10, “6.10% Secured debenture due September 2030”, on September 23, 2020, pursuant to the implementation of the Amended Arrangement, a subsidiary of Canopy Growth advanced gross proceeds of $50,000 (less transaction costs of approximately $4,025) to Universal Hemp, an affiliate of the Company, pursuant to the terms of a secured debenture. In accordance with the terms of the debenture, the funds cannot be used, directly or indirectly, in connection with or for any cannabis or cannabis-related operations in the United States, unless and until such operations comply with all applicable laws of the United States. Acreage then engaged an investment advisor (the “Investment Advisor”) which, under the Investment Advisor’s sole discretion, invested on behalf of Universal Hemp, $34,019 of the proceeds on September 28, 2020. As a result, Universal Hemp, a subsidiary of the Company, acquired 34,019 class B units, at $1 par value per unit, which represented 100% financial interest in an Investment Partnership, a Canada-based limited partnership. An affiliate of the Institutional Investor holds Class A Units of the Investment Partnership. The general partner of the Investment Partnership is also an affiliate of the Institutional Investor. The class B units are held by the Institutional Investor as agent for Universal Hemp. On September 28, 2020, the Company received gross proceeds of $33,000 (less transaction costs of approximately $959) from an affiliate of the Institutional Lender (the “Lender”) and used a portion of the proceeds of this loan to retire its short-term $11,000 convertible note and its short-term note aggregating approximately $18,000 in October 2020, with the remainder being used for working capital purposes. The Lender is controlled by the Institutional Lender. The Investment Partnership is the investor in the Lender. Michigan consulting agreement Pursuant to the Consulting Services Agreement by and between Kevin Michigan, LLC, a company controlled by Kevin Murphy, and High Street (the “Michigan Consulting Agreement”), High Street provides certain consulting services to Kevin Michigan, LLC, which includes, but is not limited to, services related to application support, provisioning center administration and operation, local and state regulatory filings, human resource matters, and marketing matters. The Michigan Consulting Agreement explicitly states that High Street is not able to direct or control the business of Kevin Michigan, LLC. Additionally, there are certain leases held by and between Kevin Michigan, LLC, as lessee and certain wholly owned subsidiaries of High Street, as lessors. As of March 31, 2022, Kevin Michigan, LLC is not operational, and no consulting fees or rents has been paid to High Street or its wholly owned subsidiaries. Kevin Michigan, LLC is owned and controlled by the Company’s Chairman, Kevin Murphy. 9.75% Credit facilities due January 2026 On December 16, 2021, the Company entered into the 9.75% Credit facilities due January 2026 with a syndicate of lenders, including Viridescent Realty Trust, Inc. (“Viridescent”), an entity controlled by Kevin Murphy. Under the terms of the 9.75% Credit facilities due January 2026, a $75,000 initial draw was available immediately, an additional $25,000 delayed draw is available that must be advanced within 12 months, and a $50,000 committed accordion facility is available after December 1, 2022, provided certain financial covenants are met. Advances under the facilities bear interest at 9.75% per annum and undrawn amounts (excluding the committed accordion facility until it is available) bear interest at 3.0% per annum. Viridescent has committed $30,000 of the $100,000 available for immediate use under the Credit Facility, with third-party syndicated affiliates committing the additional $70,000. During the year ended March 31, 2022, $108 of interest expense under the facilities was attributed to Viridescent. The loan is secured by first-lien mortgages on Acreage’s wholly owned real estate and other commercial security interests. A third-party syndicate served as Administrative Agent for the transaction.

REPORTABLE SEGMENTS

REPORTABLE SEGMENTS	3 Months Ended
	Mar. 31, 2022
Segment Reporting [Abstract]
REPORTABLE SEGMENTS	REPORTABLE SEGMENTSThe Company prepares its segment reporting on the same basis that its Chief Operating Decision Maker manages the business, and makes operating decisions. The Company operates under one operating segment, which is its only reportable segment: the production and sale of cannabis products. The Company’s measure of segment performance is net income, and derives its revenue primarily from the sale of cannabis products, as well as related management or consulting services which were not material in all periods presented. All of the Company’s operations are located in the United States.

EARNINGS PER SHARE

EARNINGS PER SHARE	3 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
EARNINGS PER SHARE	EARNINGS PER SHARE Basic earnings per share are computed by dividing net loss attributable to common shareholders of the Company by the weighted average number of outstanding shares for the period. Diluted earnings per share are calculated based on the weighted number of outstanding common shares plus the dilutive effect of stock options and warrants, as if they were exercised, and restricted stock units and profits interests, as if they vested and NCI convertible units, as if they converted. Basic and diluted loss per share is as follows: Three Months Ended March 31, 2022 2021 Net loss attributable to common shareholders of the Company $ (12,694) $ (7,809) Weighted average shares outstanding - basic 106,900 102,343 Effect of dilutive securities — — Weighted average shares - diluted 106,900 102,343 Net loss per share attributable to common shareholders of the Company - basic $ (0.12) $ (0.08) Net loss per share attributable to common shareholders of the Company - diluted $ (0.12) $ (0.08) During the three months ended March 31, 2022, 5,817 Fixed warrants, 2,524 Floating warrants, 2,916 Fixed Share RSUs, 1,251 Floating Share RSUs, 1,525 Fixed Share stock options, 2,413 Floating Share stock options and 23,076 NCI convertible units

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	3 Months Ended
	Mar. 31, 2022
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	SUBSEQUENT EVENTS In December 2021, the Company secured a $150,000 Credit Facility with a syndicate of lenders. Under the terms of the Credit Facility, $100,000 was available for immediate use and a further $50,000 is available in future periods under a committed accordion option once certain, predetermined milestones are achieved. As of March 31, 2022, $75,000 was drawn under this facility and the remaining current availability was $25,000. In April 2022, the Company drew down on the remaining $25,000 under this facility. On May 3, 2022, the Company announced the sale of its cultivation and processing facility in Medford, Oregon for total consideration of $2.0 million, and closed its dispensary in Powell, Oregon. Management has reviewed all other events subsequent to March 31, 2022 through the date of issuing these financial statements and determined that no further subsequent events require adjustment or disclosure.

SIGNIFICANT ACCOUNTING POLICI_2

SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Basis of presentation and going concern	Basis of presentation and going concern The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, all adjustments consisting only of normal recurring adjustments necessary for a fair presentation have been reflected in these unaudited condensed consolidated financial statements. Operating results for the interim periods presented are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2022, or any other period. As reflected in the unaudited condensed consolidated financial statements, the Company had an accumulated deficit as of March 31, 2022, as well as a net loss and negative cash flow from operating activities for the three months ended March 31, 2022. These factors raise substantial doubt about the Company’s ability to continue as a going concern for at least one year from the issuance of these financial statements. However, management believes that substantial doubt about the Company’s ability to meet its obligations for the next twelve months from the date these financial statements were issued has been alleviated due to, but not limited to, (i) access to future capital commitments, (ii) continued sales growth from the Company’s consolidated operations, (iii) latitude as to the timing and amount of certain operating expenses as well as capital expenditures, (iv) restructuring plans that have already been put in place to improve the Company’s profitability, (v) the AFC-VRT credit facilities (refer to Note 10 for further discussion), and (vi) the anticipated Non-Core Divestitures (refer to Note 3 for further discussion), as well as access to the U.S. public equity markets. If the Company is unable to raise additional capital whenever necessary, it may be forced to decelerate or curtail its footprint build-out or other operational activities until such time as additional capital becomes available. Such limitation of the Company’s activities would allow it to slow its rate of spending and extend its use of cash until additional capital is raised. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. Management also cannot provide any assurance as to unforeseen circumstances that could occur at any time within the next twelve months or thereafter which could increase the Company’s need to raise additional capital on an immediate basis. These interim unaudited condensed consolidated financial statements and notes thereto should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the
Use of estimates	Use of estimates The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Preparation of financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities as of the dates presented and the reported amounts of revenues and expenses during the periods presented. Actual results could differ from those estimates. Significant estimates inherent in the preparation of the accompanying unaudited condensed consolidated financial statements include the fair value of assets acquired and liabilities assumed in business combinations, assumptions relating to equity-based compensation expense, estimated useful lives for property, plant and equipment and intangible assets, the valuation allowance against deferred tax assets and the assessment of potential charges on goodwill, intangible assets and investments in equity and notes receivable.
Emerging growth company	Emerging growth company The Company is an “emerging growth company” as defined in the Jumpstart Our Business Startups Act (the “JOBS Act”). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards until such time as those standards apply to private companies.
Functional and presentation currency	Functional and presentation currency The unaudited condensed consolidated financial statements and the accompanying notes are expressed in U.S. dollars. Financial metrics are presented in thousands. Other metrics, such as shares outstanding, are presented in thousands unless otherwise noted.
Basis of consolidation	Basis of consolidation The Company’s unaudited condensed consolidated financial statements include the accounts of Acreage, its subsidiaries and variable interest entities (“VIEs”) where the Company is considered the primary beneficiary, if any, after elimination of intercompany accounts and transactions. Investments in business entities in which Acreage lacks control but is able to exercise significant influence over operating and financial policies are accounted for using the equity method. The Company’s proportionate share of net income or loss of the entity is recorded in Income (loss) from investments, net in the Unaudited Condensed Consolidated Statements of Operations.
VIEs	VIEs In determining whether the Company is the primary beneficiary of a VIE, the Company assesses whether it has the power to direct matters that most significantly impact the activities of the VIE and have the obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE. There were no material consolidated VIEs as of March 31, 2022 or December 31, 2021.
Non-controlling interests (“NCI”)	Non-controlling interests (“NCI”) Non-controlling interests represent ownership interests in consolidated subsidiaries by parties that are not shareholders of Pubco. They are shown as a component of Total equity in the Unaudited Condensed Consolidated Statements of Financial Position, and the share of loss attributable to non-controlling interests is shown as a component of Net loss in the Unaudited Condensed Consolidated Statements of Operations. Changes in the parent company’s ownership that do not result in a loss of control are accounted for as equity transactions.
Restricted cash	Restricted cashRestricted cash represents funds contractually held for specific purposes and, as such, not available for general corporate purposes.
Accounts receivable valuations and reclassifications	Accounts receivable valuations and reclassificationsAccounts receivable are stated at their net realizable value. The allowance against gross trade receivables reflects the best estimate of probable losses inherent in the receivables portfolio determined on the basis of historical experience, specific allowances for known troubled accounts and other currently available information.
Net loss per share	Net loss per share Net loss per share represents the net loss attributable to shareholders divided by the weighted average number of shares outstanding during the period on an as converted basis. Basic and diluted loss per share are the same as of March 31, 2022, 2021 and 2020, as the issuance of shares upon conversion, exercise or vesting of outstanding units would be anti-dilutive in each period. There were 39,522 and 44,466 anti-dilutive shares outstanding as of March 31, 2022 and 2021, respectively.
Accounting Pronouncements Recently Adopted	Accounting Pronouncements Recently Adopted As of January 1, 2022, the Company adopted ASU 2019-12 - Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (ASU 2019-12) . ASU 2019-12 attempts to simplify aspects of accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The adoption of ASU 2019-12 did not have a material effect on the Company’s unaudited condensed consolidated financial statements. As of January 1, 2022, the Company adopted ASU 2020-01 - Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) . The new standard clarifies the interaction of accounting for the transition into and out of the equity method. The new standard also clarifies the accounting for measuring certain purchased options and forward contracts to acquire investments. The adoption of ASU 2020-01 did not have a material effect on the Company’s unaudited condensed consolidated financial statements. As of January 1, 2022, the Company adopted ASU 2021-04 - Earnings Per Share (Topic 260), Debt - Modifications and Extinguishments (Topic 470-50), Compensation - Stock Compensation (Topic 718), and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40) , which clarifies existing guidance for freestanding written call options which are equity classified and remain so after they are modified or exchanged in order to reduce diversity in practice. The standard applies prospectively to modifications or exchanges that occur after it is adopted. The adoption of ASU 2021-04 did not have a material effect on the Company’s unaudited condensed consolidated financial statements. Accounting Pronouncements Not Yet Adopted In June 2016, the FASB issued ASU 2016-13 - Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”) , which was subsequently revised by ASU 2018-19 and ASU 2020-02. The ASU introduces a new model for assessing impairment on most financial assets. Entities will be required to use a forward-looking expected loss model, which will replace the current incurred loss model, which will result in earlier recognition of allowance for losses. The ASU will be effective for the Company’s first interim period of fiscal 2023. The Company continues to evaluate the impact of this ASU on its unaudited condensed consolidated financial statements. In October 2021, the FASB issued ASU 2021-08 - Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The new standard improves the accounting for acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency. The new standard requires an entity to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with ASC 606 - Revenue from Contracts with Customers . The ASU will be effective for the Company’s first interim period of fiscal 2024. The standard should be applied prospectively to business combinations occurring on or after the effective date of the amendments. The Company does not anticipate a material impact on the Company’s unaudited condensed consolidated financial statements upon adoption.

ACQUISITIONS, DIVESTITURES AN_2

ACQUISITIONS, DIVESTITURES AND ASSETS HELD FOR SALE (Tables)	3 Months Ended
	Mar. 31, 2022
Business Combinations, Discontinued Operations And Disposal Groups [Abstract]
Purchase Price Allocations	During the three month period ended March 31, 2022, the Company did not complete any business combinations. During the year ended December 31, 2021, the Company completed the following business combinations, and has allocated the purchase price as follows: Purchase Price Allocation CWG Greenleaf Total Assets acquired: Cash and cash equivalents $ 828 $ 1,209 $ 2,037 Inventory 1,200 2,692 3,892 Other current assets 347 1,520 1,867 Capital assets, net 3,312 22,923 26,235 Operating lease right-of-use asset 1,584 2,819 4,403 Goodwill 1,482 18,619 20,101 Intangible assets, net - cannabis licenses 3,200 — 3,200 Intangible assets, net - customer relationships 1,000 — 1,000 Other non-current assets 40 189 229 Liabilities assumed: Accounts payable and accrued liabilities (464) (1,829) (2,293) Taxes payable (68) (33) (101) Operating lease liability, current (193) (315) (508) Other current liabilities 3 (294) (291) Operating lease liability, non-current (1,391) (2,504) (3,895) Fair value of net assets acquired $ 10,880 $ 44,996 $ 55,876 Consideration paid: Settlement of pre-existing relationship 10,880 44,996 $ 55,876 Total consideration $ 10,880 $ 44,996 $ 55,876
Assets and Liabilities Held for Sale	The tables below present the preliminary fair values of the assets and liabilities classified as held for sale on the Unaudited Condensed Consolidated Statements of Financial Position for the years ended March 31, 2022 and December 31, 2021, respectively, and are subject to change based on developments during the sales process. March 31, 2022 Oregon (1) Cash $ 347 Accounts receivable, net 140 Inventory 309 Other current assets 4 Total current assets classified as held-for-sale 800 Capital assets, net 1,673 Operating lease right-of-use assets 1,556 Goodwill 2,191 Non-current assets 91 Total assets classified as held for sale $ 6,311 Accounts payable and accrued liabilities $ (564) Operating lease liability, current (434) Total current liabilities classified as held-for-sale (998) Operating lease liability, non-current (671) Total liabilities classified as held-for-sale $ (1,669) (1) In February 2021, a subsidiary of the Company entered into a definitive agreement and management services agreement to sell an indoor cultivation facility in Medford, Oregon and a retail dispensary in Portland, Oregon, for total consideration of $3,000, to be paid in a series of tranches based on estimated regulatory approvals which are not expected to exceed 18 months. In March 2022, the total consideration was reduced to $2,000. Additionally, in September 2021, a subsidiary of the Company entered into a definitive agreement and management services agreements to sell, upon regulatory approval, four retail dispensaries in Oregon for total consideration of $6,500, consisting of a $250 cash payment at the time of signing and a 10-month secured promissory note. December 31, 2021 Michigan (1) Oregon Total Cash $ — $ 223 $ 223 Inventory — 445 445 Notes receivable, current — 31 31 Other current assets — 9 9 Total current assets classified as held-for-sale — 708 708 Capital assets, net 1,907 2,342 4,249 Operating lease right-of-use assets — 1,695 1,695 Goodwill — 2,191 2,191 Non-current assets — 109 109 Total assets classified as held for sale $ 1,907 $ 7,045 $ 8,952 Accounts payable and accrued liabilities $ — $ (639) $ (639) Operating lease liability, current — (441) (441) Total current liabilities classified as held-for-sale — (1,080) (1,080) Operating lease liability, non-current — (787) (787) Total liabilities classified as held-for-sale $ — $ (1,867) $ (1,867) (1) As of December 31, 2021, the Company was unsuccessful in finding a satisfactory buyer for certain of its Michigan locations. As a result, the assets at these specific locations no longer meet the criteria for being classified as held-for-sale.

INTANGIBLE ASSETS AND GOODWILL

INTANGIBLE ASSETS AND GOODWILL (Tables)	3 Months Ended
	Mar. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	The following table details the intangible asset balances by major asset classes: Intangibles March 31, 2022 December 31, 2021 Finite-lived intangible assets: Management contracts $ 1,808 $ 1,511 Customer relationships 1,000 1,000 2,808 2,511 Accumulated amortization on finite-lived intangible assets: Management contracts (639) (493) Customer relationships (550) — (1,189) (493) Finite-lived intangible assets, net 1,619 2,018 Indefinite-lived intangible assets Cannabis licenses 117,080 117,677 Total intangibles, net $ 118,699 $ 119,695
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	Expected annual amortization expense for existing intangible assets subject to amortization at March 31, 2022 is as follows for each of the next five fiscal years: Amortization of Intangibles 2022 2023 2024 2025 2026 Amortization expense $ 889 $ 585 $ 145 $ — $ —
Schedule of Goodwill	The following table details the changes in the carrying amount of goodwill: Goodwill Total December 31, 2021 $ 43,310 Other Adjustments (1) 224 March 31, 2022 $ 43,534 (1) Represents adjustments related to the remeasurement of certain deferred tax assets and related adjustments within the measurement period.

INVESTMENTS (Tables)

INVESTMENTS (Tables)	3 Months Ended
	Mar. 31, 2022
Investments [Abstract]
Schedule of Investments	The carrying values of the Company’s investments in the Unaudited Condensed Consolidated Statements of Financial Position as of March 31, 2022 and December 31, 2021 are as follows: Investments March 31, 2022 December 31, 2021 Total short-term investments $ 3,401 $ — Investments held at FV-NI 36,014 35,226 Total long-term investments $ 36,014 $ 35,226
Investment Income (Loss)	Income (loss) from investments, net in the Unaudited Condensed Consolidated Statements of Operations during the three months ended March 31, 2022 and 2021 is as follows: Investment income (loss) Three Months Ended March 31, 2022 2021 Short-term investments $ 1 $ — Investments held at FV-NI 1,132 (144) Income (loss) from investments, net $ 1,133 $ (144)

NOTES RECEIVABLE (Tables)

NOTES RECEIVABLE (Tables)	3 Months Ended
	Mar. 31, 2022
Receivables [Abstract]
Schedule of Notes Receivable	Notes receivable as of March 31, 2022 and December 31, 2021 consisted of the following: March 31, 2022 December 31, 2021 Promissory notes receivable $ 27,262 $ 27,260 Line of credit receivable 7,551 12,609 Interest receivable 3,300 2,834 Allowance for notes and interest receivables (8,258) (8,036) Total notes receivable $ 29,855 $ 34,667 Less: Notes receivable, current 2,222 7,104 Notes receivable, non-current $ 27,633 $ 27,563

CAPITAL ASSETS, net (Tables)

CAPITAL ASSETS, net (Tables)	3 Months Ended
	Mar. 31, 2022
Property, Plant and Equipment [Abstract]
Schedule of Capital Assets, net	Net property, plant and equipment consisted of: March 31, 2022 December 31, 2021 Land $ 3,758 $ 3,777 Building 57,935 43,921 Right-of-use asset, finance leases 10,865 5,077 Construction in progress 17,866 7,644 Furniture, fixtures and equipment 31,590 31,325 Leasehold improvements 39,656 51,646 Capital assets, gross $ 161,670 $ 143,390 Less: accumulated depreciation (19,602) (16,593) Capital assets, net $ 142,068 $ 126,797

LEASES (Tables)

LEASES (Tables)	3 Months Ended
	Mar. 31, 2022
Leases [Abstract]
Lease Cost	Balance Sheet Information Classification March 31, 2022 December 31, 2021 Right-of-use assets Operating Operating lease right-of-use assets $ 24,571 $ 24,598 Finance Capital assets, net 10,246 4,522 Total right-of-use assets $ 34,817 $ 29,120 Lease liabilities Current Operating Operating lease liability, current $ 2,343 $ 2,145 Financing Debt, current 5,786 — Non-current Operating Operating lease liability, non-current 24,146 24,255 Financing Debt, non-current 5,257 5,245 Total lease liabilities $ 37,532 $ 31,645 Statement of Operations Information Classification Three Months Ended March 31, 2022 Three Months Ended Short-term lease expense General and administrative $ 48 $ 88 Operating lease expense General and administrative 1,248 1,046 Finance lease expense: Amortization of right of use asset Depreciation and amortization 63 63 Interest expense on lease liabilities Interest expense 212 184 Sublease income Other income (loss), net — (3) Net operating and finance lease cost $ 1,523 $ 1,290 Statement of Cash Flows Information Classification Three Months Ended Three Months Ended Cash paid for operating leases Net cash used in operating activities $ 1,257 $ 1,437 Cash paid for finance leases - interest Net cash used in operating activities $ 201 $ 169
Operating Lease, Liability, Maturity	The following represents the Company’s future minimum payments required under existing leases with initial terms of one year or more as of March 31, 2022: Maturity of lease liabilities Operating Leases (1) Finance Leases 2022 $ 3,763 $ 6,500 2023 4,823 722 2024 4,537 743 2025 4,554 766 2026 4,453 789 Thereafter 20,470 12,486 Total lease payments $ 42,600 $ 22,006 Less: interest 15,006 10,963 Present value of lease liabilities $ 27,594 $ 11,043 Weighted average remaining lease term (years) 8 2 Weighted average discount rate 9% 10% (1) Includes minimum payments under existing operating leases currently classified as held-for-sale (refer to Note 3 for further discussion).
Finance Lease, Liability, Maturity	The following represents the Company’s future minimum payments required under existing leases with initial terms of one year or more as of March 31, 2022: Maturity of lease liabilities Operating Leases (1) Finance Leases 2022 $ 3,763 $ 6,500 2023 4,823 722 2024 4,537 743 2025 4,554 766 2026 4,453 789 Thereafter 20,470 12,486 Total lease payments $ 42,600 $ 22,006 Less: interest 15,006 10,963 Present value of lease liabilities $ 27,594 $ 11,043 Weighted average remaining lease term (years) 8 2 Weighted average discount rate 9% 10% (1) Includes minimum payments under existing operating leases currently classified as held-for-sale (refer to Note 3 for further discussion).

INVENTORY (Tables)

INVENTORY (Tables)	3 Months Ended
	Mar. 31, 2022
Inventory Disclosure [Abstract]
Schedule of Inventory	The Company’s inventory balance consists of the following: March 31, 2022 December 31, 2021 Retail inventory $ 3,630 $ 3,331 Wholesale inventory 34,611 28,643 Cultivation inventory 6,988 6,367 Supplies & other 3,469 3,463 Total $ 48,698 $ 41,804

DEBT (Tables)

DEBT (Tables)	3 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
Schedule of Debt	The Company’s debt balances consist of the following: Debt balances March 31, 2022 December 31, 2021 Financing liability (failed sale-leaseback) $ 15,253 $ 15,253 Finance lease liabilities 11,043 5,245 7.50% Loan due April 2026 30,893 30,763 6.10% Secured debenture due September 2030 46,162 46,050 Note due December 2024 4,750 4,750 9.75% Credit facilities due January 2026 68,551 68,673 Total debt $ 176,652 $ 170,734 Less: current portion of debt 7,370 1,583 Total long-term debt $ 169,282 $ 169,151
Scheduled Maturities of Debt	Scheduled maturities of debt, excluding amortization of discount and issuance costs, are as follows: 2022 $ 7,321 2023 1,583 2024 1,584 2025 — 2026 108,011 Thereafter 70,547 Total payments (excluding amortization of discount and issuance costs) $ 189,046

SHAREHOLDERS_ EQUITY AND NON-_2

SHAREHOLDERS’ EQUITY AND NON-CONTROLLING INTERESTS (Tables)	3 Months Ended
	Mar. 31, 2022
Equity [Abstract]
Schedule of Stock by Class	The table below details the change in Pubco shares outstanding by class for the three months ended March 31, 2022: Shareholders’ Equity Fixed Shares Floating Shares Fixed Shares Held in Treasury Floating Shares Held in Treasury Fixed Multiple Shares Total Shares Outstanding December 31, 2021 74,665 32,962 (589) (253) 118 106,903 Issuances 255 253 — — — 508 March 31, 2022 74,920 33,215 (589) (253) 118 107,411
Schedule of Warrants	A summary of the warrants activity outstanding is as follows: Warrants Fixed Shares Floating Shares December 31, 2021 5,817 2,524 Expired — — March 31, 2022 5,817 2,524
Summarized Financial Information	Summarized financial information of HSCP is presented below. USCo2 does not have discrete financial information separate from HSCP. HSCP net asset reconciliation March 31, 2022 December 31, 2021 Current assets $ 103,620 $ 113,011 Non-current assets 391,449 375,807 Current liabilities (38,437) (29,256) Non-current liabilities (195,686) (195,791) Other NCI balances (718) (718) Accumulated equity-settled expenses (230,756) (226,596) Net assets $ 29,472 $ 36,457 HSCP/USCo2 ownership % of HSCP 17.18 % 17.24 % Net assets allocated to USCo2/HSCP $ 5,063 $ 6,285 Net assets attributable to other NCIs 718 718 Total NCI $ 5,781 $ 7,003 Three Months Ended March 31, HSCP Summarized Statement of Operations 2022 2021 Net loss allocable to HSCP/USCo2 $ (7,080) $ (4,549) HSCP/USCo2 weighted average ownership % of HSCP 17.21 % 18.40 % Net loss allocated to HSCP/USCo2 $ (1,218) $ (837) Net loss allocated to other NCIs 1 4 Net loss attributable to NCIs $ (1,217) $ (833)
Schedule of Conversions of Stock	A reconciliation of the beginning and ending amounts of convertible units is as follows: Three Months Ended March 31, Convertible Units 2022 2021 Beginning balance 23,076 24,142 Vested LLC C-1s canceled — — LLC C-1s vested — — NCI units converted to Pubco — (400) Ending balance 23,076 23,742

EQUITY-BASED COMPENSATION EXP_2

EQUITY-BASED COMPENSATION EXPENSE (Tables)	3 Months Ended
	Mar. 31, 2022
Share-based Payment Arrangement [Abstract]
Restricted stock and restricted stock unit, activity	Restricted Share Units (“RSUs”) Fixed Shares Floating Shares Restricted Share Units (Fair value information expressed in whole dollars) RSUs Weighted Average Grand Date Fair Value RSUs Weighted Average Grand Date Fair Value Unvested, January 1, 2022 3,188 $ 7.30 1,262 $ 7.39 Granted 28 $ 1.35 95 $ 1.19 Forfeited (177) $ 2.55 (21) $ 2.47 Vested (841) $ 8.81 (395) $ 8.00 Unvested, March 31, 2022 2,198 $ 7.03 941 $ 6.62 Vested and unreleased (1) 718 $ 10.70 310 $ 10.37 Outstanding, March 31, 2022 2,916 $ 7.94 1,251 $ 7.55 (1) RSUs that are vested and unreleased represent RSUs that are pending delivery.
Option activity	Stock options Fixed Shares Floating Shares Stock Options (Exercise price expressed in whole dollars) Options Weighted Average Exercise Price Options Weighted Average Exercise Price Options outstanding, January 1, 2022 1,529 $ 11.07 2,414 $ 3.06 Forfeited (4) $ 13.14 (1) $ 5.63 Options outstanding, March 31, 2022 1,525 $ 11.07 2,413 $ 3.06 Options exercisable, March 31, 2022 1,195 $ 13.06 1,894 $ 3.15

EARNINGS PER SHARE (Tables)

EARNINGS PER SHARE (Tables)	3 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Schedule of Earnings Per Share	Basic and diluted loss per share is as follows: Three Months Ended March 31, 2022 2021 Net loss attributable to common shareholders of the Company $ (12,694) $ (7,809) Weighted average shares outstanding - basic 106,900 102,343 Effect of dilutive securities — — Weighted average shares - diluted 106,900 102,343 Net loss per share attributable to common shareholders of the Company - basic $ (0.12) $ (0.08) Net loss per share attributable to common shareholders of the Company - diluted $ (0.12) $ (0.08)

NATURE OF OPERATIONS (Details)

NATURE OF OPERATIONS (Details)	Sep. 23, 2020USD ($)shares	Jun. 27, 2019shares	Mar. 31, 2022
Class of Stock [Line Items]
Share conversion (in shares)		0.5818
11065220 Canada Inc | Canopy Growth | Canopy Growth | Debenture
Class of Stock [Line Items]
Debenture amount, amount advanced | $	$ 50,000,000
Stated interest rate	6.10%
6.10% Secured debenture due September 2030
Class of Stock [Line Items]
Stated interest rate			6.10%
Fixed Shares
Class of Stock [Line Items]
Percent of share - canopy reorganization	0.7
Floating Shares
Class of Stock [Line Items]
Percent of share - canopy reorganization	0.3
PVS, Fixed Shares
Class of Stock [Line Items]
Canopy reorganization, shares exchanged (in shares)	28,000
PVS, Floating Shares
Class of Stock [Line Items]
Canopy reorganization, shares exchanged (in shares)	12,000
Fixed Multiple Share
Class of Stock [Line Items]
Percent of share - canopy reorganization	0.7
Floating Multiple Share
Class of Stock [Line Items]
Percent of share - canopy reorganization	0.3

SIGNIFICANT ACCOUNTING POLICI_3

SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Accounting Policies [Abstract]
Cash and cash equivalents	$ 32,619	$ 22,844	$ 43,180
Restricted cash	95	$ 23,097	1,098
Allowance for doubtful accounts	$ 350		$ 445
Antidilutive shares (in shares)	39,522	44,466

ACQUISITIONS, DIVESTITURES AN_3

ACQUISITIONS, DIVESTITURES AND ASSETS HELD FOR SALE (Schedule of Purchase Price Allocation) (Details) - USD ($) $ in Thousands	Jul. 02, 2018	Dec. 31, 2021	Mar. 31, 2022	Oct. 01, 2021
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]
Goodwill		$ 43,310	$ 43,534
CWG
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]
Cash and cash equivalents		828
Inventory		1,200
Other current assets		347
Capital assets, net		3,312
Operating lease right-of-use asset		1,584
Goodwill		1,482
Other non-current assets		40
Accounts payable and accrued liabilities		(464)
Taxes payable		(68)
Operating lease liability, current		(193)
Other current liabilities		3
Operating lease liability, non-current		(1,391)
Fair value of net assets acquired		10,880
Consideration paid:
Settlement of pre-existing relationship		10,880
Total consideration		10,880
CWG | Intangible assets, net - cannabis licenses
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]
Intangible assets, net		3,200
CWG | Intangible assets, net - customer relationships
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]
Intangible assets, net		1,000
Greenleaf
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]
Cash and cash equivalents		1,209
Inventory		2,692
Other current assets		1,520
Capital assets, net		22,923
Operating lease right-of-use asset		2,819
Goodwill		18,619
Intangible assets, net				$ 2,953
Other non-current assets		189
Accounts payable and accrued liabilities		(1,829)
Taxes payable		(33)
Operating lease liability, current		(315)
Other current liabilities		(294)
Operating lease liability, non-current		(2,504)
Fair value of net assets acquired		44,996
Consideration paid:
Settlement of pre-existing relationship		44,996
Total consideration	$ 8,245	44,996
Greenleaf | Intangible assets, net - cannabis licenses
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]
Intangible assets, net		0
Greenleaf | Intangible assets, net - customer relationships
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]
Intangible assets, net		0
Total
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]
Cash and cash equivalents		2,037
Inventory		3,892
Other current assets		1,867
Capital assets, net		26,235
Operating lease right-of-use asset		4,403
Goodwill		20,101
Other non-current assets		229
Accounts payable and accrued liabilities		(2,293)
Taxes payable		(101)
Operating lease liability, current		(508)
Other current liabilities		(291)
Operating lease liability, non-current		(3,895)
Fair value of net assets acquired		55,876
Consideration paid:
Settlement of pre-existing relationship		55,876
Total consideration		55,876
Total | Intangible assets, net - cannabis licenses
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]
Intangible assets, net		3,200
Total | Intangible assets, net - customer relationships
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]
Intangible assets, net		$ 1,000

ACQUISITIONS, DIVESTITURES AN_4

ACQUISITIONS, DIVESTITURES AND ASSETS HELD FOR SALE (Acquisition Narrative) (Details) - USD ($) $ / shares in Units, $ in Thousands, shares in Millions	Oct. 01, 2021	Apr. 30, 2021	Mar. 19, 2021	Jul. 02, 2018	Dec. 31, 2021
Greenleaf
Business Acquisition [Line Items]
Total purchase price	$ 44,996
CWG
Business Acquisition [Line Items]
Percentage of voting interests acquired		100.00%
Total consideration					$ 10,880
Settlement of pre-existing relationship					10,880
CWG | Line of Credit
Business Acquisition [Line Items]
Total consideration		$ 9,321
Settlement of pre-existing relationship		$ 1,559
Greenleaf
Business Acquisition [Line Items]
Percentage of voting interests acquired	100.00%
Total consideration				$ 8,245	44,996
Settlement of pre-existing relationship					$ 44,996
Sellers notes issued	$ 42,043			$ 6,096
Number of shares issued (in shares)				1.2
Share price (USD per share)				$ 7.73
Line of credit issued				$ 31,200
Payments to acquire notes receivable	3,300
Intangible assets, net	$ 2,953
Greenleaf | Promissory Note
Business Acquisition [Line Items]
Promissory notes issued				$ 12,500
NCC Real Estate, LLC
Business Acquisition [Line Items]
Total consideration			$ 850
Fair value of previously held interest			$ 286

ACQUISITIONS, DIVESTITURES AN_5

ACQUISITIONS, DIVESTITURES AND ASSETS HELD FOR SALE (Assets Held for Sale) (Details) $ in Thousands	1 Months Ended		3 Months Ended
	Sep. 30, 2021USD ($)dispensary	Feb. 28, 2021USD ($)	Mar. 31, 2022USD ($)	Mar. 31, 2021USD ($)	Dec. 31, 2021USD ($)
Business Combinations, Discontinued Operations And Disposal Groups [Abstract]
Write down (recovery) of assets held-for-sale			$ 874	$ (8,616)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Total current assets classified as held-for-sale			6,311		$ 8,952
Total current liabilities classified as held-for-sale			(1,669)		(1,867)
Held for sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash					223
Accounts and notes receivable, current					31
Inventory					445
Other current assets					9
Total current assets classified as held-for-sale					708
Capital assets, net					4,249
Operating lease right-of-use assets					1,695
Goodwill					2,191
Non-current assets					109
Total assets classified as held for sale					8,952
Accounts payable and accrued liabilities					(639)
Operating lease liability, current					(441)
Total current liabilities classified as held-for-sale					(1,080)
Operating lease liability, non-current					(787)
Total liabilities classified as held-for-sale					(1,867)
Consideration received on disposal			2,000
Held for sale | Michigan
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash					0
Accounts and notes receivable, current					0
Inventory					0
Other current assets					0
Total current assets classified as held-for-sale					0
Capital assets, net					1,907
Operating lease right-of-use assets					0
Goodwill					0
Non-current assets					0
Total assets classified as held for sale					1,907
Accounts payable and accrued liabilities					0
Operating lease liability, current					0
Total current liabilities classified as held-for-sale					0
Operating lease liability, non-current					0
Total liabilities classified as held-for-sale					0
Held for sale | Oregon
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash			347		223
Accounts and notes receivable, current			140		31
Inventory			309		445
Other current assets			4		9
Total current assets classified as held-for-sale			800		708
Capital assets, net			1,673		2,342
Operating lease right-of-use assets			1,556		1,695
Goodwill			2,191		2,191
Non-current assets			91		109
Total assets classified as held for sale			6,311		7,045
Accounts payable and accrued liabilities			(564)		(639)
Operating lease liability, current			(434)		(441)
Total current liabilities classified as held-for-sale			(998)		(1,080)
Operating lease liability, non-current			(671)		(787)
Total liabilities classified as held-for-sale			$ (1,669)		$ (1,867)
Consideration received on disposal	$ 6,500	$ 3,000
Consideration received on disposal period		18 months
Number of dispensaries to be sold | dispensary	4
Consideration due at signing	$ 250
Promissory note term	10 months

Intangible Assets and Goodwil_2

Intangible Assets and Goodwill (Schedule of Intangible Assets) (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross	$ 2,808	$ 2,511
Accumulated amortization on finite-lived intangible assets	(1,189)	(493)
Finite-lived intangible assets, net	1,619	2,018
Indefinite-lived intangible assets	117,080	117,677
Total intangibles, net	118,699	119,695
Management contracts
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross	1,808	1,511
Accumulated amortization on finite-lived intangible assets	(639)	(493)
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross	1,000	1,000
Accumulated amortization on finite-lived intangible assets	$ (550)	$ 0

Intangible Assets and Goodwil_3

Intangible Assets and Goodwill (Intangible Asset Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Acquired Indefinite-lived Intangible Assets [Line Items]
Impairment of intangible assets, finite-lived		$ 818
Reversal of deferred tax liabilities		205
Amortization of intangible assets	$ 696	$ 541
Minimum
Acquired Indefinite-lived Intangible Assets [Line Items]
Useful life	9 months 18 days
Maximum
Acquired Indefinite-lived Intangible Assets [Line Items]
Useful life	2 years
Customer-Related Intangible Assets
Acquired Indefinite-lived Intangible Assets [Line Items]
Useful life	9 months 18 days
Management contracts
Acquired Indefinite-lived Intangible Assets [Line Items]
Useful life	2 years

Intangible Assets and Goodwil_4

Intangible Assets and Goodwill (Future Amortization Table) (Details) $ in Thousands	Mar. 31, 2022USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2022	$ 889
2023	585
2024	145
2025	0
2026	$ 0

Intangible Assets and Goodwil_5

Intangible Assets and Goodwill (Goodwill) (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2022USD ($)
Goodwill [Roll Forward]
Beginning balance	$ 43,310
Other adjustments	224
Ending balance	$ 43,534

INVESTMENTS (Schedule Investmen

INVESTMENTS (Schedule Investment Holdings) (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Investments [Abstract]
Total short-term investments	$ 3,401	$ 0
Investments held at FV-NI	36,014	35,226
Total long-term investments	$ 36,014	$ 35,226

INVESTMENTS (Schedule of Invest

INVESTMENTS (Schedule of Investment Income) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Net Investment Income [Line Items]
Income (loss) from investments, net	$ 1,133	$ (144)
Short-term investments
Net Investment Income [Line Items]
Income (loss) from investments, net	1	0
Investments held at FV-NI
Net Investment Income [Line Items]
Income (loss) from investments, net	$ 1,132	$ (144)

INVESTMENTS (Narrative) (Detail

INVESTMENTS (Narrative) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	Sep. 23, 2020	Mar. 31, 2022	Sep. 28, 2020
Subsidiary or Equity Method Investee [Line Items]
Proceeds from secured debenture	$ 50
Amount invested			$ 34,019
Financial interest in the Investment partnership			100.00%
6.10% Secured debenture due September 2030
Subsidiary or Equity Method Investee [Line Items]
Stated interest rate	6.10%	6.10%
GIC
Subsidiary or Equity Method Investee [Line Items]
Investment interest rate		0.20%
Investment, term		1 year
MB Melody LP
Subsidiary or Equity Method Investee [Line Items]
Amount invested			$ 34,019
Financial interest in the Investment partnership			100.00%
MB Melody LP | Class B Units
Subsidiary or Equity Method Investee [Line Items]
Number of shares acquired (in shares)			34,019
Par value (USD per share)			$ 1
Financial interest in the Investment partnership			100.00%

NOTES RECEIVABLE (Schedule of N

NOTES RECEIVABLE (Schedule of Notes Receivable) (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest receivable	$ 3,300	$ 2,834
Allowance for notes and interest receivables	(8,258)	(8,036)
Total notes receivable	29,855	34,667
Less: Notes receivable, current	2,222	7,104
Notes receivable, non-current	27,633	27,563
Promissory notes receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Promissory notes receivable	27,262	27,260
Line of credit receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Promissory notes receivable	$ 7,551	$ 12,609

NOTES RECEIVABLE (Narrative) (D

NOTES RECEIVABLE (Narrative) (Details) $ in Thousands	Feb. 10, 2022USD ($)	Mar. 31, 2022USD ($)payment	Mar. 31, 2021USD ($)	Dec. 31, 2021USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Interest income from loans receivable		$ 417	$ 1,465
Allowance for notes and interest receivables		(8,258)		$ (8,036)
Collection of notes receivable	$ 5,279
PATC
Accounts, Notes, Loans and Financing Receivable [Line Items]
Management fee expense		$ 2,500
Number of payments | payment		7
Maximum obligation		$ 7,150
Notes Receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loss on notes receivable		6,046		6,046
Interest Receivable, Notes
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loss on notes receivable		$ 2,212		$ 1,990

CAPITAL ASSETS, net (Details)

CAPITAL ASSETS, net (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Right-of-use asset, finance leases	$ 10,865,000		$ 5,077,000
Capital assets, gross	161,670,000		143,390,000
Less: accumulated depreciation	(19,602,000)		(16,593,000)
Capital assets, net	142,068,000		126,797,000
Depreciation	1,111,000	$ 428,000
Depreciation capitalized to inventory	1,922,000	$ 911,000
Assets related to Michigan Operations
Property, Plant and Equipment [Line Items]
Fair value of assets held for sale	0
Impairment	1,907,000
Land
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	3,758,000		3,777,000
Building
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	57,935,000		43,921,000
Construction in progress
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	17,866,000		7,644,000
Furniture, fixtures and equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	31,590,000		31,325,000
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 39,656,000		$ 51,646,000

LEASES (Balance Sheet Informati

LEASES (Balance Sheet Information) (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Right-of-use assets
Operating	$ 24,571	$ 24,598
Finance	10,246	4,522
Total right-of-use assets	34,817	29,120
Lease liabilities
Operating lease liability, current	2,343	2,145
Finance lease liability, current	5,786	0
Operating lease liability, non-current	24,146	24,255
Finance lease liability, noncurrent	5,257	5,245
Total lease liabilities	$ 37,532	$ 31,645
Finance lease, right-of-use asset, statement of financial position	Capital assets, net	Capital assets, net
Finance lease, liability, current, statement of financial position, extensible list	Debt, current	Debt, current
Finance lease, liability, non-current, statement of financial position, extensible list	Debt, non-current	Debt, non-current

LEASES (Income Statement Inform

LEASES (Income Statement Information) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Leases [Abstract]
Short-term lease expense	$ 48	$ 88
Operating lease expense	1,248	1,046
Amortization of right of use asset	63	63
Interest expense on lease liabilities	212	184
Sublease income	0	(3)
Net operating and finance lease cost	$ 1,523	$ 1,290

LEASES (Cash Flow Statement Inf

LEASES (Cash Flow Statement Information) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Leases [Abstract]
Cash paid for operating leases	$ 1,257	$ 1,437
Cash paid for finance leases - interest	$ 201	$ 169

LEASES (Lease Maturities) (Deta

LEASES (Lease Maturities) (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Operating Leases
2022	$ 3,763
2023	4,823
2024	4,537
2025	4,554
2026	4,453
Thereafter	20,470
Total lease payments	42,600
Less: interest	15,006
Present value of lease liabilities	$ 27,594
Weighted average remaining lease term (years)	8 years
Weighted average discount rate	9.00%
Finance Leases
2022	$ 6,500
2023	722
2024	743
2025	766
2026	789
Thereafter	12,486
Total lease payments	22,006
Less: interest	10,963
Present value of lease liabilities	$ 11,043	$ 5,245
Weighted average remaining lease term (years)	2 years
Weighted average discount rate	10.00%

LEASES (Narrative) (Details)

LEASES (Narrative) (Details) $ in Thousands	Mar. 31, 2022USD ($)lease
Lessee, Lease, Description [Line Items]
Number of leases not yet commenced | lease	3
Minimum
Lessee, Lease, Description [Line Items]
Lease not yet commenced, term of contract	5 years
Lease not yet commenced, annual base rent	$ 86
Maximum
Lessee, Lease, Description [Line Items]
Lease not yet commenced, term of contract	10 years
Lease not yet commenced, annual base rent	$ 432

INVENTORY (Details)

INVENTORY (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Inventory Disclosure [Abstract]
Retail inventory	$ 3,630	$ 3,331
Wholesale inventory	34,611	28,643
Cultivation inventory	6,988	6,367
Supplies & other	3,469	3,463
Total	$ 48,698	$ 41,804

DEBT (Schedule of Debt) (Detail

DEBT (Schedule of Debt) (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021	Dec. 16, 2021	Sep. 28, 2020
Debt Instrument [Line Items]
Financing liability (failed sale-leaseback)	$ 15,253	$ 15,253
Finance lease liabilities	11,043	5,245
Total debt	176,652	170,734
Less: current portion of debt	7,370	1,583
Total long-term debt	$ 169,282	169,151
7.50% Loan due April 2026
Debt Instrument [Line Items]
Stated interest rate	7.50%			7.50%
Loans	$ 30,893	30,763
6.10% Secured debenture due September 2030
Debt Instrument [Line Items]
Stated interest rate	6.10%
Loans	$ 46,162	46,050
Note due December 2024
Debt Instrument [Line Items]
Loans	$ 4,750	4,750
9.75% Credit facilities due January 2026
Debt Instrument [Line Items]
Stated interest rate	9.75%		9.75%
Loans	$ 68,551	$ 68,673

Debt (Maturities) (Details)

Debt (Maturities) (Details) $ in Thousands	Mar. 31, 2022USD ($)
Debt Disclosure [Abstract]
2022	$ 7,321
2023	1,583
2024	1,584
2025	0
2026	108,011
Thereafter	70,547
Total payments (excluding amortization of discount and issuance costs)	$ 189,046

DEBT (Narrative) (Details)

DEBT (Narrative) (Details) $ / shares in Units, shares in Thousands	Dec. 16, 2021USD ($)	Sep. 28, 2020USD ($)$ / sharesshares	Sep. 23, 2020USD ($)	Nov. 30, 2020USD ($)payment	Mar. 31, 2022USD ($)	Mar. 31, 2021USD ($)	Dec. 31, 2021USD ($)
Debt Instrument [Line Items]
Interest expense					$ 4,781,000	$ 4,857,000
Amortization of debt issuance costs					373,000	260,000
Debt discount amortization					266,000	852,000
Discounts					5,821,000		$ 6,320,000
Debt issuance costs					6,573,000		6,194,000
Interest payable					2,562,000		1,432,000
Amount invested		$ 34,019,000
Financial interest in the Investment partnership		100.00%
Repayment of short-term debt		$ 18,000,000
Amendment fee	$ 413,000
Number of debt payments | payment				10
Proceeds from issuance of debt					$ 0	$ 1,190,000
CanWell Settlement
Debt Instrument [Line Items]
Accrued loss contingency loss				$ 7,750,000
MB Melody LP
Debt Instrument [Line Items]
Amount invested		$ 34,019,000
Financial interest in the Investment partnership		100.00%
11065220 Canada Inc | Canopy Growth | Canopy Growth
Debt Instrument [Line Items]
Face amount			$ 100,000,000
Class B Units | MB Melody LP
Debt Instrument [Line Items]
Number of shares acquired (in shares) | shares		34,019
Par value (USD per share) | $ / shares		$ 1
Financial interest in the Investment partnership		100.00%
Class A Units | MB Melody LP
Debt Instrument [Line Items]
Amount invested		$ 1,019,000
Debenture | 11065220 Canada Inc | Canopy Growth | Canopy Growth
Debt Instrument [Line Items]
Stated interest rate			6.10%
Debenture amount, amount advanced			$ 50,000,000
Debt issuance costs			4,025,000
Debenture amount, amount to be advanced			$ 50,000,000
Debt term			10 years
6.10% Secured debenture due September 2030
Debt Instrument [Line Items]
Stated interest rate			6.10%		6.10%
Securities Purchase Agreement | Convertible Debt
Debt Instrument [Line Items]
Repayment of short-term debt		$ 11,000,000
7.50% Loan due April 2026
Debt Instrument [Line Items]
Stated interest rate		7.50%			7.50%
Debenture amount, amount advanced		$ 33,000,000
Debt issuance costs		$ 959,000
Debt term		3 years
9.75% Credit facilities due January 2026
Debt Instrument [Line Items]
Discounts	4,000,000
Debt issuance costs	$ 1,500,000
Stated interest rate	9.75%				9.75%
Face amount	$ 150,000,000						150,000,000
Proceeds from issuance of debt	$ 75,000,000
Collateral assignment agreements percent	1.00%
Unused line fee, percentage	3.00%
Debt instrument fee amount	$ 500,000
9.75% Credit Facilities Due January 2026, Initial Draw
Debt Instrument [Line Items]
Face amount	75,000,000
9.75% Credit Facilities Due January 2026, Delayed Draw
Debt Instrument [Line Items]
Face amount	$ 25,000,000				$ 25,000,000
Delayed draw, term for issuance	12 months
9.75% Credit Facilities Due January 2026, Committed Accordion Facility
Debt Instrument [Line Items]
Face amount	$ 50,000,000						$ 50,000,000

SHAREHOLDERS_ EQUITY AND NON-_3

SHAREHOLDERS’ EQUITY AND NON-CONTROLLING INTERESTS (Schedule of Stock by Class) (Details) shares in Thousands	3 Months Ended
	Mar. 31, 2022shares
Class Of Stock [Roll Forward]
Common stock, outstanding, beginning (in shares)	106,903
Treasury stock, period start (in shares)	(842)
Common stock, outstanding, ending (in shares)	107,411
Treasury stock, period end (in shares)	(842)
Fixed Shares | Pubco
Class Of Stock [Roll Forward]
Common stock, outstanding, beginning (in shares)	74,665
Issuances (shares)	255
Common stock, outstanding, ending (in shares)	74,920
Floating Shares | Pubco
Class Of Stock [Roll Forward]
Common stock, outstanding, beginning (in shares)	32,962
Issuances (shares)	253
Common stock, outstanding, ending (in shares)	33,215
Fixed Shares Held in Treasury | Pubco
Class Of Stock [Roll Forward]
Treasury stock, period start (in shares)	(589)
Issuances (shares)	0
Treasury stock, period end (in shares)	(589)
Floating Shares Held in Treasury | Pubco
Class Of Stock [Roll Forward]
Treasury stock, period start (in shares)	(253)
Issuances (shares)	0
Treasury stock, period end (in shares)	(253)
Fixed Multiple Shares | Pubco
Class Of Stock [Roll Forward]
Common stock, outstanding, beginning (in shares)	118
Issuances (shares)	0
Common stock, outstanding, ending (in shares)	118
Total Shares Outstanding | Pubco
Class Of Stock [Roll Forward]
Common stock, outstanding, beginning (in shares)	106,903
Issuances (shares)	508
Common stock, outstanding, ending (in shares)	107,411

SHAREHOLDERS_ EQUITY AND NON-_4

SHAREHOLDERS’ EQUITY AND NON-CONTROLLING INTERESTS (Warrants) (Details) shares in Thousands	3 Months Ended
	Mar. 31, 2022shares
Fixed Shares
Class Of Warrant Or Right [Roll Forward]
Beginning balance (in shares)	5,817
Expired (shares)	0
Ending balance (in shares)	5,817
Floating Shares
Class Of Warrant Or Right [Roll Forward]
Beginning balance (in shares)	2,524
Expired (shares)	0
Ending balance (in shares)	2,524

SHAREHOLDERS_ EQUITY AND NON-_5

SHAREHOLDERS’ EQUITY AND NON-CONTROLLING INTERESTS (Warrants Narrative) (Details)	3 Months Ended
	Mar. 31, 2022USD ($)$ / shares
Class of Warrant or Right [Line Items]
Warrants term	4 years
Warrant contractual weighted average life remaining (in years)	2 years 10 months 24 days
Aggregate intrinsic value | $	$ 0
Fixed Shares
Class of Warrant or Right [Line Items]
Exercise price (USD per share)	$ 3.15
Floating Shares
Class of Warrant or Right [Line Items]
Exercise price (USD per share)	$ 3.01

SHAREHOLDERS_ EQUITY AND NON-_6

SHAREHOLDERS’ EQUITY AND NON-CONTROLLING INTERESTS (NCI Narrative) (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2022USD ($)	Mar. 31, 2021USD ($)
Class of Stock [Line Items]
USCo2 conversion, fixed share	0.7
USCo2 conversion, floating share	0.3
USCo2 Ownership of HSCP	0.51%
USCo2 Voting Shares held by Pubco	71.33%
USCo2 non-voting shares	28.67%
HSCP ownership by LLC members	16.67%
HSCP owned by Pubco	82.82%
NCI adjustments for changes in ownership	$ 0	$ 0
Non-controlling Interests
Class of Stock [Line Items]
NCI adjustments for changes in ownership	$ (5)	$ (601)

SHAREHOLDERS_ EQUITY AND NON-_7

SHAREHOLDERS’ EQUITY AND NON-CONTROLLING INTERESTS (Noncontrolling Interest Balance Sheet Allocation) (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Subsidiary-specific information [Line Items]
Current assets	$ 103,654	$ 112,979
Non-current assets	394,159	378,572
Current liabilities	(83,140)	(66,793)
Non-current liabilities	(220,155)	(220,488)
Total NCI	5,781	7,003
HSCP LLC
Subsidiary-specific information [Line Items]
Current assets	103,620	113,011
Non-current assets	391,449	375,807
Current liabilities	(38,437)	(29,256)
Non-current liabilities	(195,686)	(195,791)
Other NCI balances	(718)	(718)
Accumulated equity-settled expenses	(230,756)	(226,596)
Net assets	29,472	36,457
Net assets allocated to USCo2/HSCP	5,063	6,285
Net assets attributable to other NCIs	$ 718	$ 718
HSCP LLC | HSCP/USCo2
Subsidiary-specific information [Line Items]
HSCP/USCo2 ownership % of HSCP	17.18%	17.24%

SHAREHOLDERS_ EQUITY AND NON-_8

SHAREHOLDERS’ EQUITY AND NON-CONTROLLING INTERESTS (Noncontrolling Interest, P&L Allocation) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Subsidiary-specific information [Line Items]
Net loss allocable to HSCP/USCo2	$ (13,911)	$ (8,642)
Net loss attributable to NCIs	(1,217)	(833)
HSCP LLC
Subsidiary-specific information [Line Items]
Net loss allocable to HSCP/USCo2	$ (7,080)	$ (4,549)
HSCP/USCo2 weighted average ownership % of HSCP	17.21%	18.40%
Net loss allocated to HSCP/USCo2	$ (1,218)	$ (837)
Net loss allocated to other NCIs	$ 1	$ 4

SHAREHOLDERS_ EQUITY AND NON-_9

SHAREHOLDERS’ EQUITY AND NON-CONTROLLING INTERESTS (Schedule of Conversions by Stock) (Details) - shares shares in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Convertible Units Outstanding [Roll Forward]
Beginning balance	23,076	24,142
Vested LLC C-1s canceled	0	0
LLC C-1s vested	0	0
NCI units converted to Pubco	0	(400)
Ending balance	23,076	23,742

EQUITY-BASED COMPENSATION EXP_3

EQUITY-BASED COMPENSATION EXPENSE (Expense by Plan) (Details) - Equity-based compensation - Plan shares in Thousands	3 Months Ended
	Mar. 31, 2022shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of outstanding stock	15.00%
Shares available for grant (in shares)	11,595

EQUITY-BASED COMPENSATION EXP_4

EQUITY-BASED COMPENSATION EXPENSE (RSU) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	Jun. 24, 2020	Mar. 31, 2022	Mar. 31, 2021
Weighted Average Grant Date Fair Value
Equity-based compensation expense		$ 4,159	$ 6,042
Restricted Stock Units (RSUs)
Weighted Average Grant Date Fair Value
Granted (USD per share)	$ 6.41
Requisite service period		3 years
Equity-based compensation expense		$ 3,877	5,025
Fair value		$ 1,882	$ 5,667
Weighted average remaining contractual term		1 year
Aggregate intrinsic value, outstanding		$ 4,897
Unrecognized compensation expense		$ 12,340
Unrecognized compensation expense, period		1 year
Restricted Stock Units, Fixed
RSUs
Beginning Balance (shares)		3,188
Granted (shares)		28
Forfeited (shares)		(177)
Vested (shares)		(841)
Ending Balance (shares)		2,198
Vested and unreleased (shares)		718
Outstanding (shares)		2,916
Weighted Average Grant Date Fair Value
Beginning Balance (USD per share)		$ 7.30
Granted (USD per share)		1.35
Forfeited (USD per share)		2.55
Vested (USD per share)		8.81
Ending Balance (USD per share)		7.03
Vested and unreleased (USD per share)		10.70
Outstanding (USD per share)		$ 7.94
Restricted Stock Units, Floating
RSUs
Beginning Balance (shares)		1,262
Granted (shares)		95
Forfeited (shares)		(21)
Vested (shares)		(395)
Ending Balance (shares)		941
Vested and unreleased (shares)		310
Outstanding (shares)		1,251
Weighted Average Grant Date Fair Value
Beginning Balance (USD per share)		$ 7.39
Granted (USD per share)		1.19
Forfeited (USD per share)		2.47
Vested (USD per share)		8
Ending Balance (USD per share)		6.62
Vested and unreleased (USD per share)		10.37
Outstanding (USD per share)		$ 7.55

EQUITY-BASED COMPENSATION EXP_5

EQUITY-BASED COMPENSATION EXPENSE (Options) (Details) - USD ($) $ / shares in Units, shares in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Weighted Average Exercise Price
Weighted average remaining contractual term	6 years
Weighted average remaining contractual term, exercisable	7 years
Equity-based compensation expense	$ 4,159,000	$ 6,042,000
Cost not yet recognized	$ 1,241,000
Fixed Shares
Options
Beginning balance (shares)	1,529
Forfeited (shares)	(4)
Ending balance (shares)	1,525
Exercisable (shares)	1,195
Weighted Average Exercise Price
Beginning balance (USD per share)	$ 11.07
Forfeited (USD per share)	13.14
Ending balance (USD per share)	11.07
Exercisable (USD per share)	$ 13.06
Aggregate intrinsic value for options outstanding	$ 0
Floating Shares
Options
Beginning balance (shares)	2,414
Forfeited (shares)	(1)
Ending balance (shares)	2,413
Exercisable (shares)	1,894
Weighted Average Exercise Price
Beginning balance (USD per share)	$ 3.06
Forfeited (USD per share)	5.63
Ending balance (USD per share)	3.06
Exercisable (USD per share)	$ 3.15
Options
Weighted Average Exercise Price
Vesting period	3 years
Equity-based compensation expense	$ 282,000	$ 1,017,000
Unrecognized compensation expense, period	1 year
Options | Minimum
Weighted Average Exercise Price
Expiration period	5 years
Weighted average remaining contractual term	5 years
Options | Maximum
Weighted Average Exercise Price
Expiration period	10 years
Weighted average remaining contractual term	5 years

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Commitments and Prior Plan of Arrangement with Canopy Growth) (Details) $ in Thousands	Mar. 31, 2022USD ($)	Jun. 19, 2019company
Commitments and Contingencies Disclosure [Abstract]
Maximum obligation under lines of credit receivable | $	$ 15,150
Number of companies involved In agreement | company		2

COMMITMENTS AND CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES (Second Amendment to the Arrangement Agreement) (Details) $ / shares in Units, $ in Thousands	Sep. 23, 2020shares	Jun. 24, 2020USD ($)$ / shares
Business Acquisition [Line Items]
Cash payment | $		$ 37,500
Fixed shares percent - canopy reorganization | $ / shares		$ 0.3048
Exerciseable period - canopy reorganization		30 days
Expiration period - canopy reorganization		10 years
Canopy Growth
Business Acquisition [Line Items]
Maximum number of shares allowed for issuance under agreement (in shares)	32,700,000
Restricted Stock Units (RSUs)
Business Acquisition [Line Items]
Weighted average grant date fair value (USD per share) | $ / shares		$ 6.41
Fixed Shares
Business Acquisition [Line Items]
Percent of share - canopy reorganization	0.7
Floating Shares
Business Acquisition [Line Items]
Percent of share - canopy reorganization	0.3
PVS, Fixed Shares
Business Acquisition [Line Items]
Canopy reorganization, shares exchanged (in shares)	28,000
PVS, Floating Shares
Business Acquisition [Line Items]
Canopy reorganization, shares exchanged (in shares)	12,000
Fixed Multiple Share
Business Acquisition [Line Items]
Percent of share - canopy reorganization	0.7
Floating Multiple Share
Business Acquisition [Line Items]
Percent of share - canopy reorganization	0.3

COMMITMENTS AND CONTINGENCIES_3

COMMITMENTS AND CONTINGENCIES (Debenture) (Details) - Canopy Growth - Canopy Growth - 11065220 Canada Inc	Sep. 23, 2020USD ($)
Business Acquisition [Line Items]
Face amount	$ 100,000,000
Debenture
Business Acquisition [Line Items]
Debenture amount, amount advanced	50,000,000
Debenture amount, amount to be advanced	$ 50,000,000
Interest coverage ratio	2
Stated interest rate	6.10%
Debt term	10 years
Period non-core divestitures are completed	18 months

COMMITMENTS AND CONTINGENCIES_4

COMMITMENTS AND CONTINGENCIES (Surety bonds) (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2022USD ($)
Commitments and Contingencies Disclosure [Abstract]
Indemnification obligation, surety bonds	$ 5,000

COMMITMENTS AND CONTINGENCIES_5

COMMITMENTS AND CONTINGENCIES (Canwell Settlement) (Details) - CanWell Settlement - USD ($) $ in Thousands	1 Months Ended	17 Months Ended
	Nov. 30, 2020	Mar. 31, 2022
Loss Contingencies [Line Items]
Accrued loss contingency loss	$ 7,750
Repayments of promissory note		$ 3,000

COMMITMENTS AND CONTINGENCIES_6

COMMITMENTS AND CONTINGENCIES (New York outstanding litigation and Lease Dispute) (Details)	Nov. 02, 2018defendant
New York Outstanding Litigation
Loss Contingencies [Line Items]
Number of defendants	16

COMMITMENTS AND CONTINGENCIES_7

COMMITMENTS AND CONTINGENCIES (Compass Neuroceuticals Litigation) (Details) - Acreage Georgia Vs Compass - USD ($) $ in Thousands	Mar. 08, 2022	Feb. 28, 2021
Loss Contingencies [Line Items]
Litigation, amount sought from other party		$ 1,000
Loss contingency, damages sought		$ 9,000
Amount awarded to the Company	$ 694

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details) $ / shares in Units, shares in Thousands	Dec. 16, 2021USD ($)	Sep. 28, 2020USD ($)$ / sharesshares	Sep. 23, 2020USD ($)	May 31, 2021USD ($)promissoryNote	Mar. 31, 2022USD ($)	Dec. 31, 2021USD ($)
Related Party Transaction [Line Items]
Number of promissory notes sold | promissoryNote				2
Amount invested		$ 34,019,000
Financial interest in the Investment partnership		100.00%
Repayment of short-term debt		$ 18,000,000
6.10% Secured debenture due September 2030
Related Party Transaction [Line Items]
Stated interest rate			6.10%		6.10%
7.50% Loan due April 2026
Related Party Transaction [Line Items]
Stated interest rate		7.50%			7.50%
Debenture amount, amount advanced		$ 33,000,000
Debt issuance costs		959,000
9.75% Credit facilities due January 2026
Related Party Transaction [Line Items]
Stated interest rate	9.75%				9.75%
Face amount	$ 150,000,000					$ 150,000,000
Unused line fee, percentage	3.00%
9.75% Credit Facilities Due January 2026, Initial Draw
Related Party Transaction [Line Items]
Face amount	$ 75,000,000
9.75% Credit Facilities Due January 2026, Delayed Draw
Related Party Transaction [Line Items]
Face amount	25,000,000				$ 25,000,000
9.75% Credit Facilities Due January 2026, Committed Accordion Facility
Related Party Transaction [Line Items]
Face amount	50,000,000					$ 50,000,000
Notes Receivable | Disposed of by Sale, Promissory Note | Viridescent Realty Trust, Inc
Related Party Transaction [Line Items]
Proceeds from sale of finance receivables				$ 28,000
Notes Receivable | Disposed of by Sale, Additional Cash | Viridescent Realty Trust, Inc
Related Party Transaction [Line Items]
Proceeds from sale of finance receivables				$ 26,000
MB Melody LP
Related Party Transaction [Line Items]
Amount invested		$ 34,019,000
Financial interest in the Investment partnership		100.00%
Viridescent Realty Trust, Inc | 9.75% Credit facilities due January 2026
Related Party Transaction [Line Items]
Debt instrument, committed amount	30,000,000
Interest expense, related party					$ 108,000
Viridescent Realty Trust, Inc | 9.75% Credit Facilities Due January 2026, Initial Draw
Related Party Transaction [Line Items]
Debt instrument, committed amount	100,000,000
11065220 Canada Inc | Canopy Growth | Canopy Growth
Related Party Transaction [Line Items]
Face amount			$ 100,000,000
Third-Party Syndicated Affiliates | 9.75% Credit facilities due January 2026
Related Party Transaction [Line Items]
Debt instrument, committed amount	$ 70,000,000
Class B Units | MB Melody LP
Related Party Transaction [Line Items]
Number of shares acquired (in shares) | shares		34,019
Par value (USD per share) | $ / shares		$ 1
Financial interest in the Investment partnership		100.00%
Debenture | 11065220 Canada Inc | Canopy Growth | Canopy Growth
Related Party Transaction [Line Items]
Stated interest rate			6.10%
Debenture amount, amount advanced			$ 50,000,000
Debt issuance costs			$ 4,025,000
Convertible Debt | Securities Purchase Agreement
Related Party Transaction [Line Items]
Repayment of short-term debt		$ 11,000,000

REPORTABLE SEGMENTS (Details)

REPORTABLE SEGMENTS (Details)	3 Months Ended
	Mar. 31, 2022segment
Segment Reporting [Abstract]
Number of reportable segments	1

EARNINGS PER SHARE (Details)

EARNINGS PER SHARE (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021		Dec. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Net loss attributable to common shareholders of the Company	$ (12,694)	$ (7,809)
Weighted average shares outstanding - basic (in share)	106,900	102,343	[1]
Effect of dilutive securities (in shares)	$ 0	$ 0
Weighted average shares - diluted (in share)	106,900	102,343	[1]
Net loss per share attributable to common shareholders of the Company - basic (USD per share)	$ (0.12)	$ (0.08)	[1]
Net loss per share attributable to common shareholders of the Company - diluted (USD per share)	$ (0.12)	$ (0.08)	[1]
Antidilutive shares (in shares)	39,522	44,466
Restricted Stock Units, Fixed
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Outstanding (shares)	2,916
Restricted Stock Units, Floating
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Outstanding (shares)	1,251
Fixed Shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Outstanding (shares)	1,525			1,529
Floating Shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Outstanding (shares)	2,413			2,414
Fixed Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares (in shares)	5,817	7,131
Floating Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares (in shares)	2,524	3,087
Restricted Stock Units, Fixed
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares (in shares)		4,441
Restricted Stock Units, Floating
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares (in shares)		2,431
Fixed Shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares (in shares)		1,511
Floating Shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares (in shares)		2,123
NCI Convertible Units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares (in shares)		23,742
[1]	Presentation of March 31, 2021 figures have been revised.

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details) - USD ($)	Dec. 16, 2021	Apr. 30, 2022	Mar. 31, 2022	Mar. 31, 2021	May 03, 2022	Dec. 31, 2021
Subsequent Event [Line Items]
Debt, non-current			$ 189,046,000
Proceeds from issuance of debt			0	$ 1,190,000
9.75% Credit facilities due January 2026
Subsequent Event [Line Items]
Face amount	$ 150,000,000					$ 150,000,000
Amount available for immediate use						100,000,000
Debt, non-current			75,000,000
Proceeds from issuance of debt	75,000,000
9.75% Credit Facilities Due January 2026, Committed Accordion Facility
Subsequent Event [Line Items]
Face amount	50,000,000					$ 50,000,000
9.75% Credit Facilities Due January 2026, Delayed Draw
Subsequent Event [Line Items]
Face amount	$ 25,000,000		$ 25,000,000
Subsequent Event | Disposal Group, Not Discontinued Operations | Medford Cultivation and Processing Facility
Subsequent Event [Line Items]
Consideration received on disposal					$ 2,000,000
Subsequent Event | 9.75% Credit Facilities Due January 2026, Delayed Draw
Subsequent Event [Line Items]
Proceeds from issuance of debt		$ 25,000,000